FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jaffer Ajani

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Anatomy

Esophagogastric Junction

Co-author Network

Publications

TOP 3
Roopma Wadhwa; Mariela A Blum; Kazuki Sudo; Takashi Taketa; Jaffer A Ajani
Modern oncological approaches to gastric adenocarcinoma.
Heath D Skinner; James W Welsh; Jaffer A Ajani; James D Cox; Alfredo E Echeverria; Wayne L Hofstetter; Ritsuko Komaki; Steven H Lin; Matthew R McCurdy; Jeffrey N Myers; Michael S O'Reilly; Vlad C Sandulache; Thomas M Guerrero
Metformin use and improved response to therapy in esophageal adenocarcinoma.
Shumei Song; John Stroehlein; Jaffer A Ajani; Chia-Hsin Chan; Arlene Correa; Marta Davila; Wayne L Hofstetter; Soichiro Honjo; Hui-Kuan Lin; Dipen M Maru; Lopa Mishra
Loss of TGF-β adaptor β2SP activates notch signaling and SOX9 expression in esophageal adenocarcinoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jaffer Ajani (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Roopma Wadhwa; Mariela A Blum; Kazuki Sudo; Takashi Taketa; Jaffer A Ajani
Modern oncological approaches to gastric adenocarcinoma.
Gastroenterology clinics of North America 2013;42(2):359-69.
2013: Heath D Skinner; James W Welsh; Jaffer A Ajani; James D Cox; Alfredo E Echeverria; Wayne L Hofstetter; Ritsuko Komaki; Steven H Lin; Matthew R McCurdy; Jeffrey N Myers; Michael S O'Reilly; Vlad C Sandulache; Thomas M Guerrero
Metformin use and improved response to therapy in esophageal adenocarcinoma.
Acta oncologica (Stockholm, Sweden) 2013;52(5):1002-9.
2013: Shumei Song; John Stroehlein; Jaffer A Ajani; Chia-Hsin Chan; Arlene Correa; Marta Davila; Wayne L Hofstetter; Soichiro Honjo; Hui-Kuan Lin; Dipen M Maru; Lopa Mishra
Loss of TGF-β adaptor β2SP activates notch signaling and SOX9 expression in esophageal adenocarcinoma.
Cancer research 2013;73(7):2159-69.
2013: Takashi Taketa; Roopma Wadhawa; Mariela M Blum; Kazuki Sudo; Jaffer A Ajani
Adjuvant therapy in gastric cancer: what is the optimal approach?
Current oncology reports 2013;15(2):146-51.
2013: Xifeng Wu; Jaffer A Ajani; David W Chang; Jian Gu; Michelle A T Hildebrandt; Maosheng Huang; Weiqi Tan; Kenneth K Wang; Ernest Hawk
MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma.
Cancer prevention research (Philadelphia, Pa.) 2013;6(3):196-205.
2013: Mariela A Blum; Akihiro Suzuki; Taketa Takashi; Jaffer A Ajani
Management of localized gastric cancer.
Journal of surgical oncology 2013;107(3):265-70.
2013: Shumei Song; Jaffer A Ajani
The role of microRNAs in cancers of the upper gastrointestinal tract.
Nature reviews. Gastroenterology & hepatology 2013;10(2):109-18.
2012: Leonard L Gunderson; Michael G Haddock; Robert J Mayer; Jennifer Moughan; John E Pedersen; Tyvin A Rich; Charles R Thomas; Jaffer A Ajani; Al B Benson; Kathryn A Winter; Christopher G Willett
Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(35):4344-51.
2012: Mariela A Blum Murphy; Kazuki Sudo; Takashi Taketa; Jeffrey H Lee; Jaffer A Ajani
Surveillance for esophageal cancer: does it make sense?
Journal of the National Comprehensive Cancer Network : JNCCN 2012;10(12):1590-2.
2012: Steven H Lin; Bevan Myles; Stephen G Swisher; Peter F Thall; Lu Wang; Jaffer A Ajani; James D Cox; Wayne L Hofstetter; Ritsuko Komaki; Zhongxing Liao
Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer.
International journal of radiation oncology, biology, physics 2012;84(5):1078-85.
2012: Yuki Hayashi; Wayne L Hofstetter; Jeffrey H Lee; Steven H Lin; Dipen M Maru; Bradley Sabloff; Akihiro Suzuki; Stephen G Swisher; Takashi Taketa; James Welsh; Brian Weston; Lianchun Xiao; Manoop S Bhutani; Mariela A Blum; Jaffer A Ajani
A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer.
European journal of cancer (Oxford, England : 1990) 2012;48(18):3396-404.
2012: Prajnan Das; Vivian E Strong; Jaffer A Ajani
Adjuvant and neoadjuvant therapy for gastric cancer: taking stock of the options.
Gastrointestinal cancer research : GCR 2012;5(6):203-4.
2012: Manfred P Lutz; Christophe Mariette; Markus Moehler; Florian Otto; Tsuneo Oyama; Arnaud Roth; Josef Rueschoff; Thomas Ruhstaller; Raquel Seruca; Michael Stahl; Florian Sterzing; Eric van Cutsem; Ate van der Gaast; Jan van Lanschot; Marc Ychou; John R Zalcberg; Jaffer A Ajani; William Allum; Daniela Aust; Yung-Jue Bang; Stefano Cascinu; Michel Ducreux; Arnulf Hölscher; Janusz Jankowski; Edwin P M Jansen; Ralf Kisslich; Florian Lordick
Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer.
European journal of cancer (Oxford, England : 1990) 2012;48(16):2941-53.
2012: Jenifer L Marks; Dipen Maru; Reza J Mehran; David Rice; Jack Roth; Jaffer A Ajani; Joe Chang; Arlene M Correa; Jeremy Erasmus; Wayne Hofstetter; Jared Lee; Jeffrey H Lee; Ara Vaporciyan; Garrett Walsh; Stephen G Swisher
Salvage esophagectomy after failed definitive chemoradiation for esophageal adenocarcinoma.
The Annals of thoracic surgery 2012;94(4):1126-32; discussion 1132-3.
2012: Mariela A Blum; Jaffer A Ajani
Chemoradiation: Gastro-oesophageal cancer--is CROSSing over so hard to do?
Nature reviews. Clinical oncology 2012;9(9):493-4.
2012: Jennifer Y Pan; Angel Quin; Xifeng Wu; Jaffer A Ajani; Yubo Gong; Jian Gu; Maosheng Hung; Julie G Izzo
Association of Aurora-A (STK15) kinase polymorphisms with clinical outcome of esophageal cancer treated with preoperative chemoradiation.
Cancer 2012;118(17):4346-53.
2012: Y Hayashi; Wayne L Hofstetter; Jeffrey H Lee; S H Lin; D M Maru; R J Mehran; D C Rice; A Suzuki; Stephen G Swisher; Ara A Vaporciyan; J Welsh; M S Bhutani; Arlene M Correa; Jaffer A Ajani
Patients with high body mass index tend to have lower stage of esophageal carcinoma at diagnosis.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E 2012;25(7):614-22.
2012: Stephen R Smalley; Grant N Stemmermann; James A Martenson; Jaffer A Ajani; Jacqueline K Benedetti; Charles D Blanke; Norman C. Estes; Bryan Goldman; Leonard L Gunderson; Daniel G Haller; Scott A Hundahl; J Milburn Jessup; John S Macdonald
Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(19):2327-33.
2012: Yixing Jiang; Jaffer A Ajani
Anal margin cancer: current situation and ongoing trials.
Current opinion in oncology 2012;24(4):448-53.
2012: Steven H Lin; Radhe Mohan; Bevan Myles; Matthew Palmer; Stephen G Swisher; Caimiao Wei; Xiaomao Guo; Wayne L Hofstetter; Ritsuko Komaki; Zhongxing Liao; Jaffer A Ajani; James D Cox
Proton beam therapy and concurrent chemotherapy for esophageal cancer.
International journal of radiation oncology, biology, physics 2012;83(3):e345-51.
2012: Arya Amini; Manoop S Bhutani; Christopher Crane; Yuki Hayashi; Wayne Hofstetter; Ritsuko Komaki; Jeffrey H Lee; Zhongxing Liao; Akihiro Suzuki; Jaffer A Ajani; Pamela K Allen; Lianchun Xiao; James Welsh
Celiac node failure patterns after definitive chemoradiation for esophageal cancer in the modern era.
International journal of radiation oncology, biology, physics 2012;83(2):e231-9.
2012: Twisha Chakravarty; Christopher H Crane; Jaffer A Ajani; A Sam Beddar; Tina Marie Briere; Marc E Delclos; Sunil Krishnan; Paul F Mansfield; Henry Mok; Valerie K Reed; Prajnan Das
Intensity-modulated radiation therapy with concurrent chemotherapy as preoperative treatment for localized gastric adenocarcinoma.
International journal of radiation oncology, biology, physics 2012;83(2):581-6.
2012: James Welsh; Lianchun Xiao; Arya Amini; Yuki Hayashi; Wayne Hofstetter; Ritsuko Komaki; Zhongxing Liao; Stephen H Settle; Akihiro Suzuki; Jaffer A Ajani
Failure patterns in patients with esophageal cancer treated with definitive chemoradiation.
Cancer 2012;118(10):2632-40.
2012: Mariela A Blum; Jaffer A Ajani
Therapy: localized gastric cancer--a CLASSIC shift in the paradigm?
Nature reviews. Gastroenterology & hepatology 2012;9(4):194-5.
2012: Stephen G Swisher; Kathryn A Winter; Tsung T Wu; Jaffer A Ajani; Wayne L Hofstetter; Ritsuko U Komaki; Andre Konski; Christopher G Willett
A Phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246.
International journal of radiation oncology, biology, physics 2012;82(5):1967-72.
2012: Jaffer A Ajani; Mariela A Blum; Prajnan Das; Jeannelyn S Estrella; Keith F Fournier
Gastric cancer: apples will always be apples.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(9):1017-8; author reply 1019-20.
2012: Panteleimon Kountourakis; Jeffrey H Lee; Jaffer A Ajani; Manoop S Bhutani; Marta Davila; Julie G Izzo
Barrett's Esophagus: A Review of Biology and Therapeutic Approaches.
Gastrointestinal cancer research : GCR 2012;5(2):49-57.
2012: Takashi Taketa; Ara A Vaporciyan; James Welsh; Brian Weston; Manoop S Bhutani; Mariela A Blum; Pamela Chien; Arlene M Correa; Jeremy J Erasmus; Wayne L Hofstetter; Jeffrey H Lee; Steven H Lin; Dipen M Maru; David C Rice; Akihiro Suzuki; Stephen G Swisher; Jaffer A Ajani
Outcome of trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiation.
Oncology 2012;83(5):300-4.
2012: Akihiro Suzuki; Takashi Taketa; Brian Weston; Lianchun Xiao; Manoop S Bhutani; Mariela A Blum; Pamela L Chien; Prajnan Das; Marc E Delclos; Jeannelyn S Estrella; Keith F Fournier; Sunil Krishnan; Jeffrey H Lee; Paul F Mansfield; Aurelio Matamoros; Jaffer A Ajani
Localized gastric cancer treated with chemoradation without surgery: UTMD Anderson Cancer Center experience.
Oncology 2012;82(6):347-51.
2012: Yuki Hayashi; Mariela A Blum; Jaffer A Ajani
Advanced gastroesophageal carcinoma: an update on the current therapeutic landscape.
Onkologie 2012;35(4):204-9.
2012: Akihiro Suzuki; Stephen G Swisher; James W Welsh; Brian Weston; Lianchun Xiao; Manoop S Bhutani; Mariela A Blum; Jeremy Erasmus; Yuki Hayashi; Wayne L Hofstetter; Jeffrey H Lee; Steven H Lin; Dipen M Maru; David C Rice; Jaffer A Ajani
Nomograms for prognostication of outcome in patients with esophageal and gastroesophageal carcinoma undergoing definitive chemoradiotherapy.
Oncology 2012;82(2):108-13.
2011: James Welsh; X Ronald Zhu; Jaffer A Ajani; Lei Dong; Daniel Gomez; Wayne L Hofstetter; Ritsuko Komaki; Zhongxing Liao; Anna Likhacheva; Amin V Mayankkumar; Matthew B Palmer; Beverly A Riley; James D Cox
Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study.
International journal of radiation oncology, biology, physics 2011;81(5):1336-42.
2011: Akihiro Suzuki; Stephen G Swisher; James Welsh; Lianchun Xiao; Manoop S Bhutani; Yuki Hayashi; Wayne L Hofstetter; Jeffrey H Lee; Steven H Lin; Homer A Macapinlac; Dipen M Maru; Jaffer A Ajani
Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapy.
Cancer 2011;117(21):4823-33.
2011: Harold J Burstein; Lawrence Holt; Pamela B Mangu; David Samson; Deborah Schrag; Mark R Somerfield; Debra Zelman; Jaffer A Ajani
American Society of Clinical Oncology clinical practice guideline update on the use of chemotherapy sensitivity and resistance assays.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(24):3328-30.
2011: Robert E Glasgow; James A Hayman; David H Ilson; Mary F Mulcahy; Hans Gerdes; Jaffer A Ajani
Modern approaches to localized cancer of the esophagus.
Journal of the National Comprehensive Cancer Network : JNCCN 2011;9(8):902-11.
2011: Jaffer A Ajani; James S Barthel; David J Bentrem; Thomas A D'Amico; Prajnan Das; Crystal S Denlinger; Charles S Fuchs; Hans Gerdes; Robert E Glasgow; James A Hayman; Wayne L Hofstetter; David H Ilson; Rajesh N Keswani; Lawrence Kleinberg; W Michael Korn; A Craig Lockhart; Mary F Mulcahy; Mark B Orringer; Raymond U Osarogiagbon; James A Posey; Aaron R Sasson; Walter J Scott; Stephen Shibata; Vivian E M Strong; Thomas K Varghese; Graham Warren; Mary Kay Washington; Christopher Willett; Cameron D Wright
Esophageal and esophagogastric junction cancers.
Journal of the National Comprehensive Cancer Network : JNCCN 2011;9(8):830-87.
2011: Jaffer A Ajani
Crescendos and decrescendos: gastric and esophageal cancers.
Journal of the National Comprehensive Cancer Network : JNCCN 2011;9(8):811-3.
2011: Iain Beehuat Tan; Sze Huey Tan; Manuel Salto Tellez; Han Chong Toh; Akira Tsuburaya; Wei Kiat Wan; Wai-Keong Wong; Jeanie Wu; Khay Guan Yeoh; Wei Peng Yong; Jaffer A Ajani; Alex Boussioutas; Jae Ho Cheong; Niantao Deng; Heike Grabsch; Tatiana Ivanova; Julian Lee; Ju Seog Lee; Ming Hui Lee; Kiat Hon Lim; Sung Hoon Noh; Chee Wee Ong; Chia-Huey Ooi; Sun Young Rha; Steven Rozen; Jimmy So; Patrick Tan
Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy.
Gastroenterology 2011;141(2):476-85, 485.e1-11.
2011: Jaffer A Ajani; Mariela A Blum; Wayne L Hofstetter; James Welsh; Stephen G Swisher
Celebrate or calibrate? We say calibrate.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(19):2732; author reply 2732-3.
2011: Jeannelyn S Estrella; Wayne L Hofstetter; Jeffrey H Lee; Susan C Abraham; Jaffer A Ajani; Manoop S Bhutani; Arlene M Correa; Asif Rashid; Stephen G Swisher; Dipen M Maru
Duplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma.
The American journal of surgical pathology 2011;35(7):1045-53.
2011: Mariela Blum; Akihiro Suzuki; Jaffer A Ajani
A comprehensive review of S-1 in the treatment of advanced gastric adenocarcinoma.
Future oncology (London, England) 2011;7(6):715-26.
2011: James Welsh; Arya Amini; Anna Likhacheva; Jeremy Erasmus J; Daniel Gomez; Marta Davila; Reza J Mehran; Ritsuko Komaki; Zhongxing Liao; Wayne L Hofstetter; Jeffrey Lee H; Manoop S Bhutani; Jaffer A Ajani
Update: modern approaches to the treatment of localized esophageal cancer.
Current oncology reports 2011;13(3):157-67.
2011: Nushmia Z Khokhar; Jaffer A Ajani; Al B Benson; Yixing Jiang; Mary F Mulcahy
Refining docetaxel-containing therapy for gastric cancer.
Gastrointestinal cancer research : GCR 2011;4(3):96-105.
2011: Jae Yong Cho; Jae Yun Lim; Jae Ho Cheong; Yun-Yong Park; Se-Lyun Yoon; Soo Mi Kim; Sang-Bae Kim; Hoguen Kim; Soon Won Hong; Young Nyun Park; Sung Hoon Noh; Eun Sung Park; In-Sun Chu; Waun Ki Hong; Jaffer A Ajani; Ju Seog Lee
Gene expression signature-based prognostic risk score in gastric cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(7):1850-7.
2011: Jaffer A Ajani
GCR Graduates From Nursery School on a Fast Track to Editorial Excellence.
Gastrointestinal cancer research : GCR 2011;4(2):39.
2011: Panteleimon Kountourakis; Arlene M Correa; Wayne L Hofstetter; Jeffrey H Lee; Manoop S Bhutani; David C Rice; Ritsuko Komaki; Dipen M Maru; William A Ross; Ara A Vaporciyan; Stephen G Swisher; Jaffer A Ajani
Combined modality therapy of cT2N0M0 esophageal cancer: the University of Texas M. D. Anderson Cancer Center experience.
Cancer 2011;117(5):925-30.
2011: Mariela A Blum; Jaffer A Ajani
Many a mickle makes a muckle. Translating a gastric cancer phenotype into a bigger thing.
Onkologie 2011;34(10):499-500.
2011: Yuxin Hu; Arlene M Correa; Ashraful Hoque; Baoxiang Guan; Fei Ye; Jie Huang; Stephen G Swisher; Tsung-Teh Wu; Jaffer A Ajani; Xiao-Chun Xu
Prognostic significance of differentially expressed miRNAs in esophageal cancer.
International journal of cancer. Journal international du cancer 2011;128(1):132-43.
2010: Yuki Hayashi; Arlene M Correa; Wayne L Hofstetter; Ara A Vaporciyan; David C Rice; Garrett L Walsh; Reza J Mehran; Jeffrey H Lee; Manoop S Bhutani; Alexander Dekovich; Stephen G Swisher; Jaffer A Ajani
The influence of high body mass index on the prognosis of patients with esophageal cancer after surgery as primary therapy.
Cancer 2010;116(24):5619-27.
2010: Edgar Ben-Josef; Jennifer Moughan; Jaffer A Ajani; Marshall Flam; Leonard Gunderson; JonDavid Pollock; Robert Myerson; Rani Anne; Seth A Rosenthal; Christopher G Willett
Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(34):5061-6.
2010: Yixing Jiang; Jaffer A Ajani
Multidisciplinary management of gastric cancer.
Current opinion in gastroenterology 2010;26(6):640-6.
2010: Srikrishna V Patnana; Santosh Murthy; Lianchun Xiao; Eric M Rohren; Wayne L Hofstetter; Stephen G Swisher; Zhongxing Liao; Jeffrey H Lee; Manoop S Bhutani; Homer A Macapinlac; Xuemei Wang; Jaffer A Ajani
Critical role of surgery in patients with gastroesophageal carcinoma with a poor prognosis after chemoradiation as defined by positron emission tomography.
Cancer 2010;116(19):4487-94.
2010: Stephen G Swisher; Wayne L Hofstetter; Ritsuko Komaki; Arlene M Correa; Jeremy J Erasmus; Jeffrey H Lee; Zhongxing Liao; Dipen Maru; Reza Mehran; Shital Patel; David C Rice; Jack A Roth; Ara A Vaporciyan; Garrett L Walsh; Jaffer A Ajani
Improved long-term outcome with chemoradiotherapy strategies in esophageal cancer.
The Annals of thoracic surgery 2010;90(3):892-8; discussion 898-9.
2010: Min P Kim; Arlene M Correa; Jared Lee; David C Rice; Jack A Roth; Reza J Mehran; Garrett L Walsh; Jaffer A Ajani; Dipen M Maru; Joe Y Chang; Edith M Marom; Homer A Macapinlac; Jeff H Lee; Ara A Vaporciyan; Thomas Rice; Stephen G Swisher; Wayne L Hofstetter
Pathologic T0N1 esophageal cancer after neoadjuvant therapy and surgery: an orphan status.
The Annals of thoracic surgery 2010;90(3):884-90; discussion 890-1.
2010: Jian Gu; Jaffer A Ajani; Ernest T Hawk; Yuanqing Ye; Jeffrey H Lee; Manoop S Bhutani; Wayne L Hofstetter; Stephen G Swisher; Kenneth K Wang; Xifeng Wu
Genome-wide catalogue of chromosomal aberrations in barrett's esophagus and esophageal adenocarcinoma: a high-density single nucleotide polymorphism array analysis.
Cancer prevention research (Philadelphia, Pa.) 2010;3(9):1176-86.
2010: Jaffer A Ajani; Kathryn A Winter; Leonard L Gunderson; John Pedersen; Al B Benson; Charles Thomas; Robert J Mayer; Michael G Haddock; tyvin rich; Christopher G Willett
Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: the intergroup trial (RTOG 98-11).
Cancer 2010;116(17):4007-13.
2010: Yixing Jiang; Heath Mackley; Hua Cheng; Jaffer A Ajani
Use of K-Ras as a predictive biomarker for selecting anti-EGF receptor/pathway treatment.
Biomarkers in medicine 2010;4(4):535-41.
2010: Salah-Eddin Al-Batran; Jaffer A Ajani
Impact of chemotherapy on quality of life in patients with metastatic esophagogastric cancer.
Cancer 2010;116(11):2511-8.
2010: Jaffer A Ajani
Resectable esophageal cancer: surgery as primary therapy is not the answer, but then, what is and why?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(15):e243-4; author reply e245.
2010: Manish A Shah; Jaffer A Ajani
Gastric cancer--an enigmatic and heterogeneous disease.
JAMA : the journal of the American Medical Association 2010;303(17):1753-4.
2010: Jaffer A Ajani; Arlene M Correa; Garrett L Walsh; Ritsuko Komaki; Jeffrey H Lee; Ara A Vaporciyan; David C Rice; James C Yao; Dipen M Maru; Wayne L Hofstetter; Alexandria T Phan; Stephen G Swisher
Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junction.
Cancer 2010;116(7):1656-63.
2010: Jaffer A Ajani; Xuemei Wang; Julie G Izzo; Christopher H Crane; Cathy Eng; John M Skibber; Prajnan Das; Asif Rashid
Molecular biomarkers correlate with disease-free survival in patients with anal canal carcinoma treated with chemoradiation.
Digestive diseases and sciences 2010;55(4):1098-105.
2010: Jaffer A Ajani; Wuilbert Rodriguez; Gyorgy Bodoky; Vladimir Moiseyenko; Michail R Lichinitser; Vera Gorbunova; Ihor Vynnychenko; August Garin; Istvan Lang; Silvia Falcon
Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(9):1547-53.
2010: Soo Mi Kim; Yun-Yong Park; Eun Sung Park; Jae Yong Cho; Julie G Izzo; Di Zhang; Sang-Bae Kim; Jeffrey H Lee; Manoop S Bhutani; Stephen G Swisher; Xifeng Wu; Kevin R Coombes; Dipen Maru; Kenneth K Wang; Navtej S Buttar; Jaffer A Ajani; Ju-Seog Lee
Prognostic biomarkers for esophageal adenocarcinoma identified by analysis of tumor transcriptome.
PloS one 2010;5(11):e15074.
2010: Miria C Correa; Helena F Deus; Ana T Vasconcelos; Yuki Hayashi; Jaffer A Ajani; Srikrishna V Patnana; Jonas Almeida
AGUIA: autonomous graphical user interface assembly for clinical trials semantic data services.
BMC medical informatics and decision making 2010;10():65.
2010: Santosh Murthy; Srikrishna V Patnana; Lianchun Xiao; Eric M Rohren; Wayne L Hofstetter; Stephen G Swisher; Zhongxing Liao; Jeffrey H Lee; Manoop S Bhutani; Homer A Macapinlac; Xuemei Wang; Jaffer A Ajani
The standardized uptake value of 18-fluorodeoxyglucose positron emission tomography after chemoradiation and clinical outcome in patients with localized gastroesophageal carcinoma.
Oncology 2010;78(5-6):316-22.
2010: Jaffer A Ajani
In the ring with a raging bull: unresectable localized esophageal carcinoma.
Onkologie 2010;33(5):220-1.
2010: Yixing Jiang; Heath Mackley; Hua Cheng; Jaffer A Ajani
Anal carcinoma therapy: can we improve on 5-fluorouracil/mitomycin/radiotherapy?
Journal of the National Comprehensive Cancer Network : JNCCN 2010;8(1):135-44.
2009: Mahmoud Goodarzi; Arlene M Correa; Jaffer A Ajani; Stephen G Swisher; Wayne L Hofstetter; Sushovan Guha; Michael T Deavers; Asif Rashid; Dipen M Maru
Anti-phosphorylated histone H3 expression in Barrett's esophagus, low-grade dysplasia, high-grade dysplasia, and adenocarcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009;22(12):1612-21.
2009: Heta Javeri; Lianchun Xiao; Eric M Rohren; Jeffrey H Lee; Zhongxing Liao; Wayne L Hofstetter; Dipen Maru; Manoop S Bhutani; Stephen G Swisher; Homer A Macapinlac; Xuemei Wang; Jaffer A Ajani
The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinoma.
Cancer 2009;115(22):5184-92.
2009: William D Bolton; Wayne L Hofstetter; Ashleigh M Francis; Arlene M Correa; Jaffer A Ajani; Manoop S Bhutani; Jeremy J Erasmus; Ritsuko Komaki; Dipen M Maru; Reza J Mehran; David C Rice; Jack A Roth; Ara A Vaporciyan; Garrett L Walsh; Stephen G Swisher
Impact of tumor length on long-term survival of pT1 esophageal adenocarcinoma.
The Journal of thoracic and cardiovascular surgery 2009;138(4):831-6.
2009: Fadi Braiteh; Arlene M Correa; Wayne L Hofstetter; David C Rice; Ara A Vaporciyan; Garrett L Walsh; Jack A Roth; Reza J Mehran; Stephen G Swisher; Jaffer A Ajani
Association of age and survival in patients with gastroesophageal cancer undergoing surgery with or without preoperative therapy.
Cancer 2009;115(19):4450-8.
2009: Hushan Yang; Jian Gu; Kenneth K Wang; Wei Zhang; Jinliang Xing; Zhinan Chen; Jaffer A Ajani; Xifeng Wu
MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(18):5744-52.
2009: Jaffer A Ajani
Accomplishments in gastrointestinal oncology in 2008: conclusion.
Gastrointestinal cancer research : GCR 2009;3(5 Supplement 2):S79.
2009: Salah-Eddin Al-Batran; Jaffer A Ajani
Accomplishments in 2008 in the management of advanced gastroesophageal cancer.
Gastrointestinal cancer research : GCR 2009;3(5 Supplement 2):S58-61.
2009: Yixing Jiang; Eric T Kimchi; Kevin F Staveley-O'Carroll; Hua Cheng; Jaffer A Ajani
Assessment of K-ras mutation: a step toward personalized medicine for patients with colorectal cancer.
Cancer 2009;115(16):3609-17.
2009: Jaffer A Ajani
Chemotherapy and radiation resistance: version 2.0.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(16):2735-6; author reply 2737-8.
2009: Grace L Smith; Benjamin David Smith; Thomas A Buchholz; Zhongxing Liao; Melenda Jeter; Stephen G Swisher; Wayne L Hofstetter; Jaffer A Ajani; Mary F McAleer; Ritsuko Komaki; James D Cox
Patterns of care and locoregional treatment outcomes in older esophageal cancer patients: The SEER-Medicare Cohort.
International journal of radiation oncology, biology, physics 2009;74(2):482-9.
2009: Rachel Lagaly; Ashley Horak; Jeffrey H Lee; Paul F Mansfield; Jaffer A Ajani
Patient with advanced gastric cancer responds twice to the same systemic therapy.
Gastrointestinal cancer research : GCR 2009;3(3):115-7.
2009: Jinliang Xing; Jaffer A Ajani; Meng Chen; Julie G Izzo; Jie Lin; Zhinan Chen; Jian Gu; Xifeng Wu
Constitutive short telomere length of chromosome 17p and 12q but not 11q and 2p is associated with an increased risk for esophageal cancer.
Cancer prevention research (Philadelphia, Pa.) 2009;2(5):459-65.
2009: Jennifer Pan; Jie Lin; Julie G Izzo; Yang Liu; Jinliang Xing; Maosheng Huang; Jaffer A Ajani; Xifeng Wu
Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway.
Carcinogenesis 2009;30(5):785-92.
2009: Gang Chen; Julie Izzo; Yusuke Demizu; Feng Wang; Sushovan Guha; Xifeng Wu; Mein-Chie Hung; Jaffer A Ajani; Peng Huang
Different redox states in malignant and nonmalignant esophageal epithelial cells and differential cytotoxic responses to bile acid and honokiol.
Antioxidants & redox signaling 2009;11(5):1083-95.
2009: Björn L.D.M. Brücher; Stephen G Swisher; Alfred Königsrainer; Derek Zieker; Jörg Hartmann; Hubert Stein; Yuko Kitagawa; Simon Law; Jaffer A Ajani
Response to preoperative therapy in upper gastrointestinal cancers.
Annals of surgical oncology 2009;16(4):878-86.
2009: Dipen M Maru; Rajyalakshmi Luthra; Arlene M Correa; Jill White-Cross; Sharmila Anandasabapathy; Sunil Krishnan; Sushovan Guha; Ritsuko Komaki; Stephen G Swisher; Jaffer A Ajani; Wayne L Hofstetter; Asif Rashid
Frequent loss of heterozygosity of chromosome 1q in esophageal adenocarcinoma: loss of chromosome 1q21.3 is associated with shorter overall survival.
Cancer 2009;115(7):1576-85.
2009: Jaffer A Ajani
Future developments in esophageal cancer research.
Gastroenterology clinics of North America 2009;38(1):183-8, x.
2009: Yixing Jiang; Eric Kimchi; Jaffer A Ajani
Localized squamous cell carcinoma of the esophagus: bimodality or trimodality approach?
Future oncology (London, England) 2009;5(2):157-61.
2009: Jaffer A Ajani; Kathryn A Winter; Leonard L Gunderson; John Pedersen; Al B Benson; Charles Thomas; Robert J Mayer; Michael G Haddock; tyvin rich; Christopher G Willett
US intergroup anal carcinoma trial: tumor diameter predicts for colostomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(7):1116-21.
2009: Michelle A T Hildebrandt; Hushan Yang; Mien-Chie Hung; Julie G Izzo; Maosheng Huang; Jie Lin; Jaffer A Ajani; Xifeng Wu
Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(6):857-71.
2009: Heta Javeri; Lianchun Xiao; Eric Rohren; Ritsuko Komaki; Wayne L Hofstetter; Jeffrey H Lee; Dipen Maru; Manoop S Bhutani; Stephen G Swisher; Xuemei Wang; Jaffer A Ajani
Influence of the baseline 18F-fluoro-2-deoxy-D-glucose positron emission tomography results on survival and pathologic response in patients with gastroesophageal cancer undergoing chemoradiation.
Cancer 2009;115(3):624-30.
2009: Sai Yendamuri; Stephen G Swisher; Arlene M Correa; Wayne L Hofstetter; Jaffer A Ajani; Ashleigh Francis; Dipen Maru; Reza J Mehran; David C Rice; Jack A Roth; Garrett L Walsh; Ara A Vaporciyan
Esophageal tumor length is independently associated with long-term survival.
Cancer 2009;115(3):508-16.
2009: Ming Yin; Zhibin Hu; Dongfeng Tan; Jaffer A Ajani; Qingyi Wei
Molecular epidemiology of genetic susceptibility to gastric cancer: focus on single nucleotide polymorphisms in gastric carcinogenesis.
American journal of translational research 2009;1(1):44-54.
2009: Niraj J Gusani; Yixing Jiang; Eric T Kimchi; Kevin F Staveley-O'Carroll; Hua Cheng; Jaffer A Ajani
New pharmacological developments in the treatment of hepatocellular cancer.
Drugs 2009;69(18):2533-40.
2009: Xiaoxiang Guan; Hui Zhao; Jiangong Niu; Dongfeng Tang; Jaffer A Ajani; Qingyi Wei
The VEGF -634G>C promoter polymorphism is associated with risk of gastric cancer.
BMC gastroenterology 2009;9():77.
2009: James D Cox; Sergio Giralt; Mary L Veazie; Jaffer A Ajani; Janet M Bruner; Ka Wah Chan; Walter N Hittelman; Kelly K Hunt; Revathy B Iyer; Daniel D Karp; Deborah A Kuban; Scott M Lippman; Issam I Raad; Miguel A Rodriguez-Bigas; Leonard A Zwelling; Maurie Markman
Evaluating quality in clinical cancer research: the M.D. Anderson Cancer Center experience.
Oncology 2009;77(2):75-81.
2009: Xiaoxiang Guan; Hui Zhao; Jiangong Niu; Dongfeng Tan; Jaffer A Ajani; Qingyi Wei
Polymorphisms of TGFB1 and VEGF genes and survival of patients with gastric cancer.
Journal of experimental & clinical cancer research : CR 2009;28():94.
2009: Jaffer A Ajani
Preoperative therapy for potentially resectable localized gastric cancer.
Gastrointestinal cancer research : GCR 2009;3(1):36-7.
2009: Jaffer A Ajani; Julie G Izzo; Ju Seog Lee
Chemotherapy and radiotherapy resistance: complexity, reality, and promise.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(1):162-3; author reply 163.
2009: P Cen; Arlene M Correa; J H Lee; J H Le; D Maru; Sharmila Anandasabapathy; Zhongxing Liao; Wayne L Hofstetter; Stephen G Swisher; Ritsuko Komaki; William A Ross; Ara A Vaporciyan; Jaffer A Ajani
Adenocarcinoma of the lower esophagus with Barrett's esophagus or without Barrett's esophagus: differences in patients' survival after preoperative chemoradiation.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E 2009;22(1):32-41.
2008: Eric D Tetzlaff; Jonathan D Cheng; Jaffer A Ajani
Thromboembolism in gastrointestinal cancers.
Gastrointestinal cancer research : GCR 2008;2(6):267-72.
2008: Yuanqing Ye; Kenneth K Wang; Jian Gu; Hushan Yang; Jie Lin; Jaffer A Ajani; Xifeng Wu
Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk.
Cancer prevention research (Philadelphia, Pa.) 2008;1(6):460-9.
2008: Michael J Overman; Scott Kopetz; Sijin Wen; Paulo M Hoff; David Fogelman; Jeffrey Morris; James L Abbruzzese; Jaffer A Ajani; Robert A Wolff
Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma.
Cancer 2008;113(8):2038-45.
2008: Eric D Tetzlaff; Jonathan D Cheng; Jaffer A Ajani
Review of docetaxel in the treatment of gastric cancer.
Therapeutics and clinical risk management 2008;4(5):999-1007.
2008: Jaffer A Ajani
Gastroesophageal cancers: progress and problems.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(9):813-4.
2008: Jaffer A Ajani; James S Barthel; Tanios Bekaii-Saab; David J Bentrem; Thomas A D'Amico; Charles S Fuchs; Hans Gerdes; James A Hayman; Lisa Hazard; David H Ilson; Lawrence Kleinberg; Mary Frances McAleer; Neal J Meropol; Mary F Mulcahy; Mark B Orringer; Raymond U Osarogiagbon; James A Posey; Aaron R Sasson; Walter J Scott; Stephen Shibata; Vivian E Strong; Stephen G Swisher; Mary Kay Washington; Christopher Willett; Douglas E Wood; Cameron D Wright; Gary Yang
Esophageal cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(9):818-49.
2008: Jaffer A Ajani; Kathryn Winter; Ritsuko Komaki; David P Kelsen; Bruce D Minsky; Zhongxing Liao; Jeffrey Bradley; Mitchel Fromm; David Hornback; Christopher G Willett
Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(28):4551-6.
2008: Heta Javeri; Rohan Arora; Arlene M Correa; Wayne L Hofstetter; Jeffrey H Lee; Zhongxing Liao; Mary F McAleer; Dipen Maru; Manoop S Bhutani; Stephen G Swisher; Julie G Izzo; Jaffer A Ajani
Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus.
Cancer 2008;113(6):1302-8.
2008: Dipen M Maru; Hema Khurana; Asif Rashid; Arlene M Correa; Sharmila Anandasabapathy; Sunil Krishnan; Ritsuko Komaki; Jaffer A Ajani; Stephen G Swisher; Wayne L Hofstetter
Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus.
The American journal of surgical pathology 2008;32(9):1404-11.
2008: Jaffer A Ajani
Is the addition of cisplatin to S-1 better than S-1 alone for patients with advanced gastroesophageal cancer?
Nature clinical practice. Oncology 2008;5(9):508-9.
2008: Jaffer A Ajani
Optimizing docetaxel chemotherapy in patients with cancer of the gastric and gastroesophageal junction: evolution of the docetaxel, cisplatin, and 5-fluorouracil regimen.
Cancer 2008;113(5):945-55.
2008: Jaffer A Ajani
Are capecitabine and oxaliplatin as effective as fluorouracil and cisplatin for gastroesophageal cancer?
Nature clinical practice. Gastroenterology & hepatology 2008;5(8):414-5.
2008: J Baker; Jaffer A Ajani
Proactive nurse management guidelines for managing intensive chemotherapy regimens in patients with advanced gastric cancer.
European journal of oncology nursing : the official journal of European Oncology Nursing Society 2008;12(3):227-32.
2008: Valerie K Reed; Sunil Krishnan; Paul F Mansfield; Pryia Bhosale; Michelle Kim; Prajnan Das; Nora Janjan; Marc E Delclos; Andrew M Lowy; Barry W Feig; Peter W T Pisters; Jaffer A Ajani; Christopher H Crane
Incidence, natural history, and patterns of locoregional recurrence in gastric cancer patients treated with preoperative chemoradiotherapy.
International journal of radiation oncology, biology, physics 2008;71(3):741-7.
2008: Yixing Jiang; Eric T Kimchi; Alberto Montero; Kevin F Staveley-O'Carroll; Jaffer A Ajani
Upper gastrointestinal tumors: current status and future perspectives.
Expert review of anticancer therapy 2008;8(6):975-91.
2008: Jaffer A Ajani; Hans-Joachim Schmoll
Accomplishments in 2007 in the management of advanced gastroesophageal cancer.
Gastrointestinal cancer research : GCR 2008;2(3 Suppl):S47-50.
2008: Michelle M Kim; Paul F Mansfield; Prajnan Das; Nora Janjan; Brian D Badgwell; Alexandria T Phan; Marc E Delclos; Dipen Maru; Jaffer A Ajani; Christopher H Crane; Sunil Krishnan
Chemoradiation therapy for potentially resectable gastric cancer: clinical outcomes among patients who do not undergo planned surgery.
International journal of radiation oncology, biology, physics 2008;71(1):167-72.
2008: Jaffer A Ajani; Kathryn A Winter; Leonard L Gunderson; John Pedersen; Al B Benson; Charles Thomas; Robert J Mayer; Michael G Haddock; tyvin rich; Christopher Willett
Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2008;299(16):1914-21.
2008: James C Yao; Alexandria Phan; Paulo M Hoff; Helen X Chen; Chusilp Charnsangavej; Sai-Ching Jim Yeung; Kenneth Hess; Chaan Ng; James L Abbruzzese; Jaffer A Ajani
Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(8):1316-23.
2008: Eric D Tetzlaff; Putao Cen; Jaffer A Ajani
Emerging drugs in the treatment of advanced gastric cancer.
Expert opinion on emerging drugs 2008;13(1):135-44.
2008: Shulian Wang; Zhongxing Liao; Xiong Wei; H Helen Liu; Susan L Tucker; Chaosu Hu; Jaffer A Ajani; Alexandria Phan; Stephen G Swisher; Radhe Mohan; James D Cox; Ritsuko Komaki
Association between systemic chemotherapy before chemoradiation and increased risk of treatment-related pneumonitis in esophageal cancer patients treated with definitive chemoradiotherapy.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(3):277-82.
2008: Putao Cen; Wayne L Hofstetter; Arlene M Correa; Tsung-Teh Wu; Jeffery H Lee; William A Ross; Marta Davilla; Stephen G Swisher; Norio Fukami; Asif Rashid; Dipen Maru; Jaffer A Ajani
Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma.
Cancer 2008;112(5):1020-7.
2008: Putao Cen; Eric D Tetzlaff; Jaffer A Ajani
Contribution of capecitabine for therapy of patients with gastroesophageal cancer: an update of recent phase III results.
Therapeutics and clinical risk management 2008;4(1):137-40.
2008: Putao Cen; Wayne L Hofstetter; Jeffery H Lee; William A Ross; Tsung-Teh Wu; Stephen G Swisher; Marta Davila; Asif Rashid; Arlene M Correa; Jaffer A Ajani
Value of endoscopic ultrasound staging in conjunction with the evaluation of lymphovascular invasion in identifying low-risk esophageal carcinoma.
Cancer 2008;112(3):503-10.
2008: Prajnan Das; Christopher H Crane; Cathy Eng; Jaffer A Ajani
Prognostic factors for squamous cell cancer of the anal canal.
Gastrointestinal cancer research : GCR 2008;2(1):10-4.
2008: Eric D Tetzlaff; Arlene M Correa; Ritsuko Komaki; Stephen G Swisher; D Maru; William A Ross; Jaffer A Ajani
Significance of thromboembolic phenomena occurring before and during chemoradiotherapy for localized carcinoma of the esophagus and gastroesophageal junction.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E 2008;21(7):575-81.
2008: Michelle M Kim; Vishal Rana; Nora Janjan; Prajnan Das; Alexandria T Phan; Marc E Delclos; Paul F Mansfield; Jaffer A Ajani; Christopher H Crane; Sunil Krishnan
Clinical benefit of palliative radiation therapy in advanced gastric cancer.
Acta oncologica (Stockholm, Sweden) 2008;47(3):421-7.
2007: Jaffer A Ajani
The area between the curves gets no respect: is it because of the median madness?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(34):5531.
2007: Jaffer A Ajani
Can we understand the clinical biology of gastric cancer and exploit it? May be, but it is a challenge!
Annals of surgical oncology 2007;14(12):3290-2.
2007: Pooja R Patel; James C Yao; Kenneth Hess; Isac I Schnirer; Asif Rashid; Jaffer A Ajani
Effect of timing of metastasis/disease recurrence and histologic differentiation on survival of patients with advanced gastric cancer.
Cancer 2007;110(10):2186-90.
2007: Howard S Hochster; Eileen O'Reilly; Jaffer A Ajani; Alan P Venook
Section III: Treatment of Advanced Gastrointestinal Cancers.
Gastrointestinal cancer research : GCR 2007;1(6 Suppl):S8-S12.
2007: Lisa A Kachnic; Jaffer A Ajani; Philip A Philip
Section II: Current Approaches to Treating Localized Gastrointestinal Cancers.
Gastrointestinal cancer research : GCR 2007;1(6 Suppl):S4-7.
2007: Richard M Goldberg; John L Marshall; Jaffer A Ajani; Philip A Philip; Eileen O'Reilly; Alan P Venook
Section IV: Significance of Recent Study Results and Future Research Directions in Gastrointestinal Oncology.
Gastrointestinal cancer research : GCR 2007;1(6 Suppl):S13-6.
2007: Susan C Abraham; Alyssa M Krasinskas; Arlene M Correa; Wayne L Hofstetter; Jaffer A Ajani; Stephen G Swisher; Tsung-Teh Wu
Duplication of the muscularis mucosae in Barrett esophagus: an underrecognized feature and its implication for staging of adenocarcinoma.
The American journal of surgical pathology 2007;31(11):1719-25.
2007: Julie G Izzo; Jaffer A Ajani
Thinking in and out of the box when it comes to gastric cancer and cyclooxygenase-2.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(31):4865-7.
2007: Putao Cen; Jaffer A Ajani
Medical treatment for advanced gastroesophageal adenocarcinoma.
Current opinion in gastroenterology 2007;23(6):631-5.
2007: Jaffer A Ajani; Arlene M Correa; Stephen G Swisher; Tsung-Teh Wu
For localized gastroesophageal cancer, you give chemoradiation before surgery, but then what happens?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(27):4315-6.
2007: Pooja R Patel; Paul F Mansfield; Christopher H Crane; Tsung-Teh Wu; Jeffrey H Lee; Patrick M Lynch; Jeffrey Morris; Peter W T Pisters; Barry W Feig; Punita K Sunder; Julie G Izzo; Jaffer A Ajani
Clinical stage after preoperative chemoradiation is a better predictor of patient outcome than the baseline stage for localized gastric cancer.
Cancer 2007;110(5):989-95.
2007: David P Kelsen; Katryn A Winter; Leonard L Gunderson; Joanne Mortimer; Norman C. Estes; Daniel G Haller; Jaffer A Ajani; Walter Kocha; Bruce D Minsky; Jack A Roth; Christopher G Willett
Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(24):3719-25.
2007: Jennifer C Sims-Mourtada; Julie G Izzo; Jaffer A Ajani; K.S. Chao
Sonic Hedgehog promotes multiple drug resistance by regulation of drug transport.
Oncogene 2007;26(38):5674-9.
2007: Jaffer A Ajani; Vladimir M Moiseyenko; Sergei Tjulandin; Alejandro Majlis; Manuel Constenla; Corrado Boni; Adriano Rodrigues; Miguel Fodor; Yee Chao; Edouard Voznyi; Lucile Awad; Eric Van Cutsem
Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(22):3210-6.
2007: Jaffer A Ajani; Vladimir M Moiseyenko; Sergei Tjulandin; Alejandro Majlis; Manuel Constenla; Corrado Boni; Adriano Rodrigues; Miguel Fodor; Yee Chao; Edouard Voznyi; Cindy Marabotti; Eric Van Cutsem
Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(22):3205-9.
2007: Wayne L Hofstetter; Arlene M Correa; Neby Bekele; Jaffer A Ajani; Alexandria Phan; Ritsuko Komaki; Zhongxing Liao; Dipen Maru; Tsung-Teh Wu; Reza J Mehran; David C Rice; Jack A Roth; Ara A Vaporciyan; Garrett L Walsh; Ashleigh Francis; Shanda H Blackmon; Stephen G Swisher
Proposed modification of nodal status in AJCC esophageal cancer staging system.
The Annals of thoracic surgery 2007;84(2):365-73; discussion 374-5.
2007: Thomas Guerrero; Valen Johnson; Justin Hart; Tinsu Pan; Meena Khan; Dershan Luo; Zhongxing Liao; Jaffer A Ajani; Craig Stevens; Ritsuko Komaki
Radiation pneumonitis: local dose versus [18F]-fluorodeoxyglucose uptake response in irradiated lung.
International journal of radiation oncology, biology, physics 2007;68(4):1030-5.
2007: John L Marshall; Daniel G Haller; Aimery de Gramont; Howard S Hochster; Heinz-Josef Lenz; Jaffer A Ajani; Richard M Goldberg
Adjuvant Therapy for Stage II and III Colon Cancer: Consensus Report of the International Society of Gastrointestinal Oncology.
Gastrointestinal cancer research : GCR 2007;1(4):146-54.
2007: Prajnan Das; Christopher H Crane; Jaffer A Ajani
Current treatment for localized anal carcinoma.
Current opinion in oncology 2007;19(4):396-400.
2007: Prajnan Das; Sumita Bhatia; Cathy Eng; Jaffer A Ajani; John M Skibber; Miguel A Rodriguez-Bigas; George J Chang; Pryia Bhosale; Marc E Delclos; Sunil Krishnan; Nora Janjan; Christopher H Crane
Predictors and patterns of recurrence after definitive chemoradiation for anal cancer.
International journal of radiation oncology, biology, physics 2007;68(3):794-800.
2007: Kazumasa Fujitani; Jaffer A Ajani; Christopher H Crane; Barry W Feig; Peter W T Pisters; Nora Janjan; Garrett L Walsh; Stephen G Swisher; Ara A Vaporciyan; David Rice; Angela Welch; Jackie Baker; Josephine Faust; Paul F Mansfield
Impact of induction chemotherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocarcinoma of the stomach or gastroesophageal junction.
Annals of surgical oncology 2007;14(7):2010-7.
2007: Julie G Izzo; Usha Malhotra; Tsung-Teh Wu; Rajyalakshmi Luthra; Arlene M Correa; Stephen G Swisher; Wayne L Hofstetter; K.S. Chao; Mien-Chie Hung; Jaffer A Ajani
Clinical biology of esophageal adenocarcinoma after surgery is influenced by nuclear factor-kappaB expression.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(6):1200-5.
2007: Eric D Tetzlaff; Arlene M Correa; Jackie Baker; Joe Ensor; Jaffer A Ajani
The impact on survival of thromboembolic phenomena occurring before and during protocol chemotherapy in patients with advanced gastroesophageal adenocarcinoma.
Cancer 2007;109(10):1989-95.
2007: Yuh Sakata; Jaffer A Ajani; Masashi Fujii; Ichinosuke Hyodo; Yeul Hong Kim
Global perspectives on chemotherapy for patients with gastric carcinoma: a roundtable discussion.
Gastrointestinal cancer research : GCR 2007;1(3):107-14.
2007: Julie G Izzo; Rajyalakshmi Luthra; Tsung-Teh Wu; Arlene M Correa; Madan G Luthra; Sharmila Anandasabapathy; K.S. Chao; Mien-Chie Hung; Bharat B Aggarwal; Walter N Hittelman; Jaffer A Ajani
Molecular mechanisms in Barrett's metaplasia and its progression.
Seminars in oncology 2007;34(2 Suppl 1):S2-6.
2007: Kaye M Reid-Lombardo; Greer Gay; Lina Patel-Parekh; Jaffer A Ajani; John H Donohue
Treatment of gastric adenocarcinoma may differ among hospital types in the United States, a report from theNational Cancer Data Base.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2007;11(4):410-9; discussion 419-20.
2007: Jaffer A Ajani
Recent Developments in Cytotoxic Therapy for Advanced Gastric or Gastroesophageal Carcinoma: The Phase III Trials.
Gastrointestinal cancer research : GCR 2007;1(2 Suppl):S16-21.
2007: Jaffer A Ajani
New proposal for postsurgery pathologic staging of esophageal or gastroesophageal junction adenocarcinoma: why bother?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(7):906-7; author reply 908-9.
2007: Julie G Izzo; Tsung-Teh Wu; Xifeng Wu; Joe Ensor; Rajyalakshmi Luthra; Jennifer Pan; Arlene Correa; Stephen G Swisher; K.S. Chao; Walter N Hittelman; Jaffer A Ajani
Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adenocarcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(6):698-707.
2007: Kim L Wang; Tsung-Teh Wu; In Seon Choi; Huamin Wang; Erika Resetkova; Erika Reseetkova; Arlene M Correa; Wayne L Hofstetter; Stephen G Swisher; Jaffer A Ajani; Asif Rashid; Constance T Albarracin
Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Cancer 2007;109(4):658-67.
2007: Li-Wei Wang; Qi Li; Zhao-Lai Hua; Fei Zhou; Xie Keping; Wei Daoyan; James Yao; Jaffer A Ajani
[Expression of transcription factor Sp1 in human gastric cancer tissue and its correlation with prognosis].
Zhonghua zhong liu za zhi [Chinese journal of oncology] 2007;29(2):107-11.
2007: Madan G Luthra; Jaffer A Ajani; Julie G Izzo; Joe Ensor; Tsung-Teh Wu; Asif Rashid; LI Zhang; Alexandria Phan; Norio Fukami; Rajyalakshmi Luthra
Decreased expression of gene cluster at chromosome 1q21 defines molecular subgroups of chemoradiotherapy response in esophageal cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(3):912-9.
2007: Julie G Izzo; Rajyalakshmi Luthra; Jennifer Sims-Mourtada; K.S. Chao; Jeffrey H Lee; Tsung-The Wu; Arlene M Correa; Madan Luthra; Bharat Aggarwal; Mien-Chie Hung; Jaffer A Ajani
Emerging molecular targets in esophageal cancers.
Gastrointestinal cancer research : GCR 2007;1(4 Suppl 2):S3-6.
2007: Zhibin Hu; Jaffer A Ajani; Qingyi Wei
Molecular epidemiology of gastric cancer: current status and future prospects.
Gastrointestinal cancer research : GCR 2007;1(1):12-9.
2007: James C Yao; Jun X Zhang; Asif Rashid; Sai-Ching Jim Yeung; Janio Szklaruk; Kenneth Hess; Keping Xie; Lee Ellis; James L Abbruzzese; Jaffer A Ajani
Clinical and in vitro studies of imatinib in advanced carcinoid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(1):234-40.
2007: Tsung-Teh Wu; Lucian R Chirieac; Susan C Abraham; Alyssa M Krasinskas; Huamin Wang; Asif Rashid; Arlene M Correa; Wayne L Hofstetter; Jaffer A Ajani; Stephen G Swisher
Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome.
The American journal of surgical pathology 2007;31(1):58-64.
2007: William A Ross; Firas Alkassab; Patrick M Lynch; Gregory D Ayers; Jaffer A Ajani; Jeffrey H Lee; Mike M Bismar
Evolving role of self-expanding metal stents in the treatment of malignant dysphagia and fistulas.
Gastrointestinal endoscopy 2007;65(1):70-6.
2007: John F Bruzzi; Stephen G Swisher; Mylene T Truong; Reginald F Munden; Wayne L Hofstetter; Homer A Macapinlac; Arlene M Correa; Osama Mawlawi; Jaffer A Ajani; Ritsuko Komaki; Norio Fukami; Jeremy J Erasmus
Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy.
Cancer 2007;109(1):125-34.
2007: Heinz-Josef Lenz; Fa-Chyi Lee; Daniel G Haller; Deepti Singh; Al B Benson; Dirk Strumberg; Ronald Yanagihara; James C Yao; Alexandria Phan; Jaffer A Ajani
Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II study.
Cancer 2007;109(1):33-40.
2006: Rajyalakshmi Luthra; Madan G Luthra; Julie G Izzo; Tsung-Teh Wu; Enrique Lopez-Alvarez; Usha Malhotra; In Seon Choi; LI Zhang; Jaffer A Ajani
Biomarkers of response to preoperative chemoradiation in esophageal cancers.
Seminars in oncology 2006;33(6 Suppl 11):S2-5.
2006: Jaffer A Ajani
Standard of care for gastric cancer based on meta-analysis? Treading on thin ice or it is very nice!
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(34):5473-4; author reply 5474-6.
2006: Pooja R Rohatgi; James C Yao; Kenneth Hess; Isac I Schnirer; Asif Rashid; Paul F Mansfield; Peter W T Pisters; Jaffer A Ajani
Outcome of gastric cancer patients after successful gastrectomy: influence of the type of recurrence and histology on survival.
Cancer 2006;107(11):2576-80.
2006: Lina Shao; Walter N Hittelman; Jie Lin; Hushan Yang; Jaffer A Ajani; Xifeng Wu
Deficiency of cell cycle checkpoints and DNA repair system predispose individuals to esophageal cancer.
Mutation research 2006;602(1-2):143-50.
2006: Julie G Izzo; Arlene M Correa; Tsung-Teh Wu; Usha Malhotra; K.S. Chao; Rajyalakshmi Luthra; Joe Ensor; Alexander Dekovich; Zhongxing Liao; Walter N Hittelman; Bharat B Aggarwal; Jaffer A Ajani
Pretherapy nuclear factor-kappaB status, chemoradiation resistance, and metastatic progression in esophageal carcinoma.
Molecular cancer therapeutics 2006;5(11):2844-50.
2006: Jennifer C Sims-Mourtada; Julie G Izzo; Smith Apisarnthanarax; Tsung-Teh Wu; Usha Malhotra; Rajyalakshmi Luthra; Zhongxing Liao; Ritsuko Komaki; Albert J van der Kogel; Jaffer A Ajani; K.S. Chao
Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation response.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(21):6565-72.
2006: Masashi Kanai; Daoyan Wei; Qiang Li; Zhiliang Jia; Jaffer A Ajani; Xiangdong Le; James Yao; Keping Xie
Loss of Krüppel-like factor 4 expression contributes to Sp1 overexpression and human gastric cancer development and progression.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(21):6395-402.
2006: Eric Van Cutsem; Vladimir M Moiseyenko; Sergei Tjulandin; Alejandro Majlis; Manuel Constenla; Corrado Boni; Adriano Rodrigues; Miguel Fodor; Yee Chao; Edouard Voznyi; Marie-Laure Risse; Jaffer A Ajani
Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(31):4991-7.
2006: Kim L Wang; Qinghua Yang; Karen R Cleary; Stephen G Swisher; Arlene M Correa; Ritsuko Komaki; Jaffer A Ajani; Asif Rashid; Stanley R Hamilton; Tsung-Teh Wu
The significance of neuroendocrine differentiation in adenocarcinoma of the esophagus and esophagogastric junction after preoperative chemoradiation.
Cancer 2006;107(7):1467-74.
2006: Pooja R Rohatgi; Paul F Mansfield; Christopher H Crane; Tsung-Teh Wu; Punita K Sunder; William A Ross; Jeffrey S Morris; Peter W T Pisters; Barry W Feig; Leonard L Gunderson; Jaffer A Ajani
Surgical pathology stage by American Joint Commission on Cancer criteria predicts patient survival after preoperative chemoradiation for localized gastric carcinoma.
Cancer 2006;107(7):1475-82.
2006: Shu-Lian Wang; Zhongxing Liao; Helen Liu; Jaffer A Ajani; Stephen Swisher; James D Cox; Ritsuko Komaki
Intensity-modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer.
World journal of gastroenterology : WJG 2006;12(34):5501-8.
2006: S Chris Malaisrie; Wayne L Hofstetter; Arlene M Correa; Jaffer A Ajani; Ritsuko Komaki; David C Rice; Ara A Vaporciyan; Garrett L Walsh; Jack A Roth; Tsung-Teh Wu; Stephen G Swisher
The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma.
Cancer 2006;107(5):967-74.
2006: Jaffer A Ajani; H Safran; C Bokemeyer; Manish A Shah; Heinz-Josef Lenz; E Van Cutsem; Howard A Burris; David Lebwohl; B Mullaney
A multi-center phase II study of BMS-247550 (Ixabepilone) by two schedules in patients with metastatic gastric adenocarcinoma previously treated with a taxane.
Investigational new drugs 2006;24(5):441-6.
2006: Jaffer A Ajani; Kathryn Winter; Gordon S Okawara; John H Donohue; Peter W T Pisters; Christopher H Crane; John Frank Greskovich; Pramila Rani Anne; Jeffrey D Bradley; Christopher Willett; tyvin rich
Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(24):3953-8.
2006: Howard Hochster; Daniel G Haller; Aimery de Gramont; Jordan D Berlin; Philip A Philip; Malcolm J Moore; Jaffer A Ajani
Consensus report of the international society of gastrointestinal oncology on therapeutic progress in advanced pancreatic cancer.
Cancer 2006;107(4):676-85.
2006: Xifeng Wu; Jian Gu; Tsung-Teh Wu; Stephen G Swisher; Zhongxin Liao; Arlene M Correa; Jun Liu; Carol J Etzel; Christopher I Amos; Maosheng Huang; Silvia S Chiang; Luka Milas; Walter N Hittelman; Jaffer A Ajani
Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(23):3789-98.
2006: Kim L Wang; Tsung-Teh Wu; Erika Resetkova; Huamin Wang; Arlene M Correa; Wayne L Hofstetter; Stephen G Swisher; Jaffer A Ajani; Asif Rashid; Stanley R Hamilton; Constance T Albarracin
Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(15):4598-604.
2006: Smith Apisarnthanarax; Mian M Alauddin; Firas Mourtada; Hisanori Ariga; Uma Raju; Osama Mawlawi; Dongmei Han; William G Bornmann; Jaffer A Ajani; Luka Milas; Juri G Gelovani; K.S. Chao
Early detection of chemoradioresponse in esophageal carcinoma by 3'-deoxy-3'-3H-fluorothymidine using preclinical tumor models.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(15):4590-7.
2006: Jaffer A Ajani
Chemotherapy for advanced gastric or gastroesophageal cancer: defining the contributions of docetaxel.
Expert opinion on pharmacotherapy 2006;7(12):1627-31.
2006: Jaffer A Ajani
Review of capecitabine as oral treatment of gastric, gastroesophageal, and esophageal cancers.
Cancer 2006;107(2):221-31.
2006: Jaffer A Ajani; Yixing Jiang; Josephine Faust; Baochong B Chang; Linus Ho; James C Yao; Steven Rousey; Shaker R Dakhil; Richard C Cherny; Catherine Craig; Archie Bleyer
A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma.
Investigational new drugs 2006;24(4):353-7.
2006: Jeremy J Erasmus; Reginald F Munden; Mylene T Truong; Jeremy J Ho; Wayne L Hofstetter; Homer A Macapinlac; Arlene M Correa; Tsung-Teh Wu; John F Bruzzi; Edith M Marom; Bradley S Sabloff; Jaffer A Ajani; Ritsuko Komaki; Zhongxing Liao; Jeffrey H Lee; Norio Fukami; Robert S Bresalier; Stephen G Swisher
Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imaging.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(5):478-86.
2006: Jaffer A Ajani
Rapid development of S-1 in the west for therapy of advanced gastric carcinoma.
Gan to kagaku ryoho. Cancer & chemotherapy 2006;33 Suppl 1():117-20.
2006: Jaffer A Ajani; Linus Ho; Jackie Baker; Marga Oortgiesen; Arnavaz Eduljee; J Randolph Hecht; Dov Michaeli
An open-label, multinational, multicenter study of G17DT vaccination combined with cisplatin and 5-fluorouracil in patients with untreated, advanced gastric or gastroesophageal cancer: the GC4 study.
Cancer 2006;106(9):1908-16.
2006: Wataru Yasui; Jaffer A Ajani; Masahiko Nishiyama; Atsushi Ohtsu; Eiichi Tahara
Current progress of cancer chemotherapy The Fifteenth International Symposium of the Hiroshima Cancer Seminar, October 2005.
Cancer science 2006;97(4):328-31.
2006: Prajnan Das; Norio Fukami; Jaffer A Ajani
Combined modality therapy of localized gastric and esophageal cancers.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(4):375-82.
2006: Jaffer A Ajani; Tanios Bekaii-Saab; Thomas A D'Amico; Charlie S Fuchs; Michael K Gibson; Melvyn Goldberg; James A Hayman; David H Ilson; Milind Javle; Scott Kelley; Robert C Kurtz; Gershon Yehuda Locker; Neal J Meropol; Bruce D Minsky; Mark B Orringer; Raymond U Osarogiagbon; James A Posey; Jack Roth; Aaron R Sasson; Stephen G Swisher; Douglas E Wood; Yun Yen
Gastric Cancer Clinical Practice Guidelines.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(4):350-66.
2006: Jaffer A Ajani; Tanios Bekaii-Saab; Thomas A D'Amico; Charlie S Fuchs; Michael K Gibson; Melvyn Goldberg; James A Hayman; David H Ilson; Milind Javle; Scott Kelley; Robert C Kurtz; Gershon Yehuda Locker; Neal J Meropol; Bruce D Minsky; Mark B Orringer; Raymond U Osarogiagbon; James A Posey; Jack Roth; Aaron R Sasson; Stephen G Swisher; Douglas E Wood; Yun Yen
Esophageal Cancer Clinical Practice Guidelines.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(4):328-47.
2006: Shulian Wang; Zhongxing Liao; Yuan Chen; Joe Y Chang; Melenda Jeter; Thomas Guerrero; Jaffer A Ajani; Alexandria Phan; Stephen G Swisher; Pamela Allen; James D Cox; Ritsuko Komaki
Esophageal cancer located at the neck and upper thorax treated with concurrent chemoradiation: a single-institution experience.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(3):252-9.
2006: Yan Gu; Stephen G Swisher; Jaffer A Ajani; Arlene M Correa; Wayne L Hofstetter; Zhongxing Liao; Ritsuko Komaki; Asif Rashid; Stanley R Hamilton; Tsung-Teh Wu
The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation.
Cancer 2006;106(5):1017-25.
2006: Shu-lian Wang; Zhongxing Liao; Ara A Vaporciyan; Susan L Tucker; Helen Liu; Xiong Wei; Stephen G Swisher; Jaffer A Ajani; James D Cox; Ritsuko Komaki
Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.
International journal of radiation oncology, biology, physics 2006;64(3):692-9.
2006: Zhongxing Liao; Hongji Liu; Stephen G Swisher; Luo Wang; Tsung-Teh Wu; Arlene M Correa; Jack A Roth; James D Cox; Ritsuko Komaki; Jaffer A Ajani; Qingyi Wei
Polymorphism at the 3'-UTR of the thymidylate synthase gene: a potential predictor for outcomes in Caucasian patients with esophageal adenocarcinoma treated with preoperative chemoradiation.
International journal of radiation oncology, biology, physics 2006;64(3):700-8.
2006: Julie G Izzo; Usha Malhotra; Tsung-Teh Wu; Joe Ensor; Rajyalakshmi Luthra; Jeffrey H Lee; Stephen G Swisher; Zhongxing Liao; K.S. Chao; Walter N Hittelman; Bharat B Aggarwal; Jaffer A Ajani
Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(5):748-54.
2006: Orlo H Clark; Jaffer A Ajani; Al B Benson; David Byrd; Gerard M Doherty; Paul F Engstrom; David S Ettinger; John F Gibbs; Martin J Heslin; Fouad Kandeel; Anne Kessinger; Matthew H Kulke; Larry K Kvols; Albert A Nemcek; John Olson; Thomas W Ratliff; Leonard B Saltz; David E Schteingart; Manisha H Shah; Stephen Shibata
Neuroendocrine tumors.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(2):102-38.
2006: Jaffer A Ajani; Fa-Chyi Lee; Deepti A Singh; Daniel G Haller; Heinz-Josef Lenz; Al B Benson; Ronald Yanagihara; Alexandria Phan; James C Yao; Dirk Strumberg
Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(4):663-7.
2006: Pooja R Rohatgi; Stephen G Swisher; Arlene M Correa; Tsung-Teh Wu; Zhongxing Liao; Ritsuko Komaki; Garrett L Walsh; Ara A Vaporciyan; David C Rice; Robert S Bresalier; Jack A Roth; Jaffer A Ajani
Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy.
Cancer 2006;106(3):552-8.
2006: Rajyalakshmi Luthra; Tsung-Teh Wu; Madan G Luthra; Julie G Izzo; Enrique Lopez-Alvarez; LI Zhang; Jaime Bailey; Jeffrey H Lee; Robert S Bresalier; Asif Rashid; Stephen G Swisher; Jaffer A Ajani
Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(2):259-67.
2006: Eric D Tetzlaff; Josephine Faust; Jaffer A Ajani
Longterm survival of a Western patient with metastatic gastric cancer treated with S-1 plus cisplatin.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2006;9(2):140-3.
2006: Pooja R Rohatgi; Arlene M Correa; Stephen G Swisher; Tsung-Teh Wu; Zhongxing Liao; Ritsuko Komaki; Garrett L Walsh; Ara A Vaporciyan; J H Lee; David C Rice; Jack A Roth; Jaffer A Ajani
Gender-based analysis of esophageal cancer patients undergoing preoperative chemoradiation: differences in presentation and therapy outcome.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E 2006;19(3):152-7.
2006: S Chris Malaisrie; Wayne L Hofstetter; Arlene M Correa; Jaffer A Ajani; Ritsuko Komaki; Zhongxing Liao; Alexandria Phan; David C Rice; Ara A Vaporciyan; Garrett L Walsh; Sandeep Lahoti; Jeffrey H Lee; Robert S Bresalier; Jack A Roth; Stephen G Swisher
Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinoma.
The Journal of thoracic and cardiovascular surgery 2006;131(1):65-72.
2005: Shumei Song; Scott M Lippman; Yiyu Zou; Xiaofeng Ye; Jaffer A Ajani; Xiao-Chun Xu
Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-beta 2 expression.
Oncogene 2005;24(56):8268-76.
2005: Xifeng Wu; Charles Lu; Silvia S Chiang; Jaffer A Ajani
Pharmacogenetics in esophageal cancer.
Seminars in oncology 2005;32(6 Suppl 9):S87-9.
2005: Luka Milas; Uma Raju; Zhongxing Liao; Jaffer A Ajani
Targeting molecular determinants of tumor chemo-radioresistance.
Seminars in oncology 2005;32(6 Suppl 9):S78-81.
2005: Julie G Izzo; Usha Malhotra; Tseung T Wu; Joe Ensor; Ilona M Babenko; Stephen G Swisher; Arlene Correa; Robert S Bresalier; Walter N Hittelman; Jaffer A Ajani
Impact of cyclin D1 A870G polymorphism in esophageal adenocarcinoma tumorigenesis.
Seminars in oncology 2005;32(6 Suppl 9):S11-5.
2005: Jaffer A Ajani; Victoria Allgood
Molecular mechanisms in cancer: what should clinicians know?
Seminars in oncology 2005;32(6 Suppl 8):2-4.
2005: Jaffer A Ajani
Introduction.
Seminars in oncology 2005;32(6 Suppl 8):1.
2005: Prajnan Das; Jaffer A Ajani
Gastric and gastro-oesophageal cancer therapy.
Expert opinion on pharmacotherapy 2005;6(16):2805-12.
2005: Pooja R Rohatgi; Stephen G Swisher; Arlene M Correa; Tsung-Teh Wu; Zhongxing Liao; Ritsuko Komaki; Garrett L Walsh; Ara A Vaporciyan; David C Rice; Jack A Roth; Jaffer A Ajani
Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response.
Cancer 2005;104(11):2365-72.
2005: Lina Shao; Jie Lin; Maosheng Huang; Jaffer A Ajani; Xifeng Wu
Predictors of esophageal cancer risk: assessment of susceptibility to DNA damage using comet assay.
Genes, chromosomes & cancer 2005;44(4):415-22.
2005: Sanjay Gupta; Marcella M Johnson; Ravi Murthy; Kamran Ahrar; Michael J Wallace; David C Madoff; Stephen E McRae; Marshall E Hicks; Sujaya Rao; Jean-Nicolas Vauthey; Jaffer A Ajani; James C Yao
Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
Cancer 2005;104(8):1590-602.
2005: David Hong; Simon Lunagomez; E Edmund Kim; Jeffery H Lee; Robert S Bresalier; Stephen G Swisher; Tsung-Teh Wu; Jeffery Morris; Zhongxing Liao; Ritsuko Komaki; Jaffer A Ajani
Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma.
Cancer 2005;104(8):1620-6.
2005: Jaffer A Ajani; Josephine Faust; Kazumasa Ikeda; James C Yao; Hiroshi Anbe; Kelli L Carr; Michele Houghton; Peter Urrea
Phase I pharmacokinetic study of S-1 plus cisplatin in patients with advanced gastric carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):6957-65.
2005: Jaffer A Ajani; Chris H Takimoto; Carlos R Becerra; Alejandro Silva; Luis Baez; Allen Cohn; Pierre Major; Makio Kamida; Kevie Feit; Robert L De Jager
A phase II clinical and pharmacokinetic study of intravenous exatecan mesylate (DX-8951f) in patients with untreated metastatic gastric cancer.
Investigational new drugs 2005;23(5):479-84.
2005: Pooja R Rohatgi; Stephen G Swisher; Arlene M Correa; Tsung-Teh Wu; Zhongxing Liao; Ritsuko Komaki; Garrett Walsh; Ara A Vaporciyan; Patrick M Lynch; David C Rice; Jack A Roth; Jaffer A Ajani
Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus.
Cancer 2005;104(7):1349-55.
2005: Jaffer A Ajani; Miguel Fodor; Sergei Tjulandin; Vladimir M Moiseyenko; Yee Chao; Sebastiao Cabral Filho; Alejandro Majlis; Sylvie Assadourian; Eric Van Cutsem
Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5660-7.
2005: Gauri R Varadhachary; Jaffer A Ajani
Preoperative and adjuvant therapies for upper gastrointestinal cancers.
Expert review of anticancer therapy 2005;5(4):719-25.
2005: Bita Esmaeli; Dominick Golio; Linda Lubecki; Jaffer A Ajani
Canalicular and nasolacrimal duct blockage: an ocular side effect associated with the antineoplastic drug S-1.
American journal of ophthalmology 2005;140(2):325-7.
2005: Lixia Liu; Wayne L Hofstetter; Asif Rashid; Stephen G Swisher; Arlene M Correa; Jaffer A Ajani; Stanley R Hamilton; Tsung-Teh Wu
Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma.
The American journal of surgical pathology 2005;29(8):1079-85.
2005: Jaffer A Ajani
Carcinoma of the esophagus: is biology screaming in my deaf ears?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(19):4256-8.
2005: James C Yao; Jennifer F Tseng; Samidha Worah; Kenneth R Hess; Paul F Mansfield; Christopher H Crane; Isac I Schnirer; Satish Reddy; Silvia S Chiang; Azmeena Najam; Christina Yu; Geoffrey G Giacco; Keping Xie; Tsung-Teh Wu; Barry W Feig; Peter W T Pisters; Jaffer A Ajani
Clinicopathologic behavior of gastric adenocarcinoma in Hispanic patients: analysis of a single institution's experience over 15 years.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(13):3094-103.
2005: Banke Agarwal; Stephen G Swisher; Jaffer A Ajani; Kaitlyn Kelly; Ritsuko Komaki; Emad M Abu-Hamda; Arlene M Correa; Jack A Roth
Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
The Annals of thoracic surgery 2005;79(5):1716-23.
2005: Stephen G Swisher; Wayne L Hofstetter; Tsung-Teh Wu; Arlene M Correa; Jaffer A Ajani; Ritsuko Komaki; Lucian R Chirieac; Kelly K Hunt; Zhongxing Liao; Alexandria Phan; David C Rice; Ara A Vaporciyan; Garrett L Walsh; Jack A Roth
Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT).
Annals of surgery 2005;241(5):810-7; discussion 817-20.
2005: Lucian R Chirieac; Stephen G Swisher; Jaffer A Ajani; Ritsuko Komaki; Arlene M Correa; Jeffrey S Morris; Jack A Roth; Asif Rashid; Stanley R Hamilton; Tsung-Teh Wu
Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation.
Cancer 2005;103(7):1347-55.
2005: Ashraful Hoque; Scott M Lippman; Tsung-Teh Wu; Ya Xu; Zheng D Liang; Stephen G Swisher; Hongfu Zhang; Liyu Cao; Jaffer A Ajani; Xiao-Chun Xu
Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention.
Carcinogenesis 2005;26(4):785-91.
2005: Lucian R Chirieac; Stephen G Swisher; Arlene M Correa; Jaffer A Ajani; Ritsuko Komaki; Asif Rashid; Stanley R Hamilton; Tsung-Teh Wu
Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(6):2229-36.
2005: Zhen Zhang; Zhongxing Liao; Jing Jin; Jaffer A Ajani; Joe Y Chang; Melenda Jeter; Thomas Guerrero; Craig W Stevens; Stephen G Swisher; Linus Ho; James Yao; Pamela Allen; James D Cox; Ritsuko Komaki
Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy.
International journal of radiation oncology, biology, physics 2005;61(3):656-64.
2005: Jaffer A Ajani; Paul F Mansfield; Christopher H Crane; Tsung-Teh Wu; Simon Lunagomez; Patrick M Lynch; Nora Janjan; Barry W Feig; Josephine Faust; James C Yao; Rebecca Nivers; Jeff Morris; Peter W T Pisters
Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(6):1237-44.
2005: Weida Gong; Liwei Wang; James C Yao; Jaffer A Ajani; Daoyan Wei; Kenneth Aldape; Keping Xie; Raymond Sawaya; Suyun Huang
Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(4):1386-93.
2005: Gauri R Varadhachary; Jaffer A Ajani
Gastric cancer.
Clinical advances in hematology & oncology : H&O 2005;3(2):118-24.
2005: David C Rice; Arlene M Correa; Ara A Vaporciyan; Nidhi Sodhi; W Roy Smythe; Stephen G Swisher; Garrett L Walsh; Joe B Putnam; Ritsuko Komaki; Jaffer A Ajani; Jack A Roth
Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity.
The Annals of thoracic surgery 2005;79(2):391-7; discussionn 391-7.
2005: Changhyeok An; In-Seon Choi; James C Yao; Samidha Worah; Keping Xie; Paul F Mansfield; Jaffer A Ajani; Asif Rashid; Stanley R Hamilton; Tsung-Teh Wu
Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(2 Pt 1):656-63.
2005: Pooja R Rohatgi; Stephen G Swisher; Arlene M Correa; Tsung-Teh Wu; Zhongxing Liao; Garrett L Walsh; Ara A Vaporciyan; David C Rice; Norio Fukami; Jack A Roth; Jaffer A Ajani
Comparison of clinical stage, therapy response, and patient outcome between squamous cell carcinoma and adenocarcinoma of the esophagus.
International journal of gastrointestinal cancer 2005;36(2):69-76.
2005: Jaffer A Ajani
Evolving chemotherapy for advanced gastric cancer.
The oncologist 2005;10 Suppl 3():49-58.
2005: Eric D Tetzlaff; Jaffer A Ajani
Oxaliplatin-based chemotherapy for the treatment of a metastatic carcinoid tumor.
International journal of gastrointestinal cancer 2005;36(1):55-8.
2005: Liwei Wang; Gary G Shi; James C Yao; Weida Gong; Daoyan Wei; Tsung-Teh Wu; Jaffer A Ajani; Suyun Huang; Keping Xie
Expression of endothelial nitric oxide synthase correlates with the angiogenic phenotype of and predicts poor prognosis in human gastric cancer.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2005;8(1):18-28.
2004: Zhongxing Liao; Zhen Zhang; Jing Jin; Jaffer A Ajani; Stephen G Swisher; Craig W Stevens; Linus Ho; Roy Smythe; Ara A Vaporciyan; Joe B Putnam; Garrett L Walsh; Jack A Roth; James C Yao; Pamela K Allen; James D Cox; Ritsuko Komaki
Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
International journal of radiation oncology, biology, physics 2004;60(5):1484-93.
2004: Maria A Kouvaraki; Jaffer A Ajani; Paulo Hoff; Robert Wolff; Douglas B Evans; Richard Lozano; James C Yao
Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(23):4762-71.
2004: Stephen G Swisher; Jeremy J Erasmus; Mary Maish; Arlene M Correa; Homer A Macapinlac; Jaffer A Ajani; James D Cox; Ritsuko Komaki; David Hong; Hoon K Lee; Joe B Putnam; David C Rice; W Roy Smythe; Linh Thai; Ara A Vaporciyan; Garrett L Walsh; Tsung-Teh Wu; Jack A Roth
2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma.
Cancer 2004;101(8):1776-85.
2004: Stephen G Swisher; Mary Maish; Jeremy J Erasmus; Arlene M Correa; Jaffer A Ajani; Robert S Bresalier; Ritsuko Komaki; Homer A Macapinlac; Reginald F Munden; Joe B Putnam; David Rice; W Roy Smythe; Ara A Vaporciyan; Garrett L Walsh; Tsung-Teh Wu; Jack A Roth
Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
The Annals of thoracic surgery 2004;78(4):1152-60; discussion 1152-60.
2004: Jing Jin; Zhongxing Liao; Zhen Zhang; Jaffer A Ajani; Stephen G Swisher; Joe Y Chang; Melenda Jeter; Thomas Guerrero; Craig W Stevens; Ara A Vaporciyan; Joe B Putnam; Garrett Walsh; Roy Smythe; Jack Roth; James Yao; Pamela Allen; James D Cox; Ritsuko Komaki
Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
International journal of radiation oncology, biology, physics 2004;60(2):427-36.
2004: John Whiting; Takeshi Sano; Mitsuru Sasako; Jaffer A Ajani
Report of the Seventeenth International Symposium of the Foundation for Promotion of Cancer Research: Recent Advances in Gastric Cancer.
Japanese journal of clinical oncology 2004;34(8):481-8.
2004: Matthew T Harting; Martin L Blakely; Cynthia E Herzog; Kevin P Lally; Jaffer A Ajani; Richard J Andrassy
Treatment issues in pediatric gastric adenocarcinoma.
Journal of pediatric surgery 2004;39(8):e8-10.
2004: Bouthaina S Dabaja; Dima Suki; Barbara Pro; Mark D Bonnen; Jaffer A Ajani
Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients.
Cancer 2004;101(3):518-26.
2004: Al B Benson; Jaffer A Ajani; Robert B Catalano; Constance Engelking; Steven M Kornblau; James A Martenson; Richard McCallum; Edith P Mitchell; Thomas M O'Dorisio; Everett E Vokes; Scott Wadler
Recommended guidelines for the treatment of cancer treatment-induced diarrhea.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(14):2918-26.
2004: Jaffer A Ajani; Paul F Mansfield; Nora Janjan; Jeff Morris; Peter W T Pisters; Patrick M Lynch; Barry W Feig; Robert J Myerson; Rebecca Nivers; Deborah S Cohen; Leonard L Gunderson
Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(14):2774-80.
2004: Banke Agarwal; Stephen G Swisher; Jaffer A Ajani; Kaitlyn Kelly; Christina Fanning; Ritsuko Komaki; Joe B Putnam; Emad M Abu-Hamda; Kimber L Molke; Garrett L Walsh; Arlene M Correa; Linus Ho; Zhongxing Liao; Patrick M Lynch; David C Rice; W Roy Smythe; Craig W Stevens; Ara A Vaporciyan; James Yao; Jack A Roth
Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection.
The American journal of gastroenterology 2004;99(7):1258-66.
2004: James C Yao; Liwei Wang; Daoyan Wei; Weida Gong; Manal Hassan; Tsung-Teh Wu; Paul Mansfield; Jaffer A Ajani; Keping Xie
Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(12 Pt 1):4109-17.
2004: Jaffer A Ajani; Garrett Walsh; Ritsuko Komaki; Jeff Morris; Stephen G Swisher; Joe B Putnam; Patrick M Lynch; Tsung-Teh Wu; Roy Smythe; Ara A Vaporciyan; Josephine Faust; Deborah S Cohen; Rebecca Nivers; Jack A Roth
Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction.
Cancer 2004;100(11):2347-54.
2004: Leonard L Gunderson; Daniel J Sargent; Joel E Tepper; Norman Wolmark; Michael J O'Connell; Mirsada Begovic; Cristine Allmer; Linda H Colangelo; Steven R Smalley; Daniel G Haller; James A Martenson; Robert J Mayer; tyvin rich; Jaffer A Ajani; John S Macdonald; Christopher G Willett; Richard M Goldberg
Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(10):1785-96.
2004: Yuji Ueda; Hisakazu Yamagishi; Tetsuro Yamashita; Norio Itoh; Hirosumi Itoi; Tetsuhiko Shirasaka; Jaffer A Ajani
S-1-induced, prolonged complete regression of lung metastasis from gastric cancer refractory to 5'-DFUR: a case report with pharmacokinetic study.
Japanese journal of clinical oncology 2004;34(5):282-6.
2004: Jaffer A Ajani
Operate on my stomach cancer? Oh, no--not you, or not yet!
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(9):1763-4; author reply 1764-5.
2004: Alexandria Phan; Jaffer A Ajani
Gastric carcinoma.
Current oncology reports 2004;6(3):192-8.
2004: Yixing Jiang; Liwei Wang; Weida Gong; Daoyan Wei; Xiangdong Le; James Yao; Jaffer A Ajani; James L Abbruzzese; Suyun Huang; Keping Xie
A high expression level of insulin-like growth factor I receptor is associated with increased expression of transcription factor Sp1 and regional lymph node metastasis of human gastric cancer.
Clinical & experimental metastasis 2004;21(8):755-64.
2004: Leizhen Zheng; Liwei Wang; Jaffer A Ajani; Keping Xie
Molecular basis of gastric cancer development and progression.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2004;7(2):61-77.
2004: Katsuhiko Higuchi; Wasaburo Koizumi; Satoshi Tanabe; Katsunori Saigenji; Jaffer A Ajani
Chemotherapy is more active against proximal than distal gastric carcinoma.
Oncology 2004;66(4):269-74.
2004: Qinghua Yang; Karen R Cleary; James C Yao; Stephen G Swisher; Jack A Roth; Patrick M Lynch; Ritsuko Komaki; Jaffer A Ajani; Asif Rashid; Stanley R Hamilton; Tsung-Teh Wu
Significance of post-chemoradiation biopsy in predicting residual esophageal carcinoma in the surgical specimen.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E 2004;17(1):38-43.
2004: Henry Q Xiong; Jaffer A Ajani
Treatment of colorectal cancer metastasis: the role of chemotherapy.
Cancer metastasis reviews 2004;23(1-2):145-63.
2003: Liwei Wang; Daoyan Wei; Suyun Huang; Zhihai Peng; Xiangdong Le; Tsung-Teh Wu; James Yao; Jaffer A Ajani; Keping Xie
Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(17):6371-80.
2003: Hoon K Lee; Ara A Vaporciyan; James D Cox; Susan L Tucker; Joe B Putnam; Jaffer A Ajani; Zhongxing Liao; Stephen G Swisher; Jack A Roth; W Roy Smythe; Garrett L Walsh; Radhe Mohan; Hui H Liu; Deidre Mooring; Ritsuko Komaki
Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters.
International journal of radiation oncology, biology, physics 2003;57(5):1317-22.
2003: Jean-Nicolas Vauthey; Jaffer A Ajani
Liver transplantation and hepatocellular carcinoma biology: beginning of the end of the era of educated guesses.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(23):4265-7.
2003: Jaffer A Ajani
It's the poison that killed him, you say!
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(20):3885.
2003: Katsuhiko Higuchi; Alexandria Phan; Jaffer A Ajani
Gastric cancer: advances in adjuvant and adjunct therapy.
Current treatment options in oncology 2003;4(5):413-9.
2003: Jaffer A Ajani; Josephine Faust; James Yao; Ritsuko Komaki; Craig Stevens; Stephen G Swisher; Joe B Putnam; Ara A Vaporciyan; Roy Smythe; Garrett Walsh; David Rice; Jack Roth
Irinotecan/cisplatin followed by 5-FU/paclitaxel/radiotherapy and surgery in esophageal cancer.
Oncology (Williston Park, N.Y.) 2003;17(9 Suppl 8):20-2.
2003: Jaffer A Ajani
Irinotecan and other agents in upper gastrointestinal and colorectal carcinomas. The University of Texas M. D. Anderson Cancer Center Investigators' Workshop, Volume 3. Introduction.
Oncology (Williston Park, N.Y.) 2003;17(9 Suppl 8):10-2.
2003: Stephen G Swisher; Jaffer A Ajani; Ritsuko Komaki; Jonathan C Nesbitt; Arlene M Correa; James D Cox; Sandeep Lahoti; Faye Martin; Joe B Putnam; W Roy Smythe; Ara A Vaporciyan; Garrett L Walsh; Jack A Roth
Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer.
International journal of radiation oncology, biology, physics 2003;57(1):120-7.
2003: Henry Q Xiong; Leonard L Gunderson; James Yao; Jaffer A Ajani
Chemoradiation for resectable gastric cancer.
The lancet oncology 2003;4(8):498-505.
2003: Sanjay Gupta; James C Yao; Kamran Ahrar; Michael J Wallace; Frank A Morello; David C Madoff; Ravi Murthy; Marshall E Hicks; Jaffer A Ajani
Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience.
Cancer journal (Sudbury, Mass.) 2003;9(4):261-7.
2003: Yulia Lisenko; Ashok J Kumar; James Yao; Jaffer A Ajani; Linus Ho
Leptomeningeal carcinomatosis originating from gastric cancer: report of eight cases and review of the literature.
American journal of clinical oncology 2003;26(2):165-70.
2003: Arthur Y Hung; Christopher Crane; Marc E Delclos; Matthew T. Ballo; Jaffer A Ajani; Edward Lin; Barry W Feig; John M Skibber; Nora Janjan
Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.
Cancer 2003;97(5):1195-202.
2003: Isac I Schnirer; James C Yao; Jaffer A Ajani
Carcinoid--a comprehensive review.
Acta oncologica (Stockholm, Sweden) 2003;42(7):672-92.
2003: James C Yao; Paul F Mansfield; Peter W T Pisters; Barry W Feig; Nora Janjan; Christopher Crane; Jaffer A Ajani
Combined-modality therapy for gastric cancer.
Seminars in surgical oncology 2003;21(4):223-7.
2003: Paulo M Hoff; Everardo D Saad; Jaffer A Ajani; Yvonne Lassere; Cynthia Wenske; Diana Medgyesy; Sunita Dwivedy; Mark Russo; Richard Pazdur
Phase I study with pharmacokinetics of S-1 on an oral daily schedule for 28 days in patients with solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1):134-42.
2002: T Christopher Windham; Paula M Termuhlen; Jaffer A Ajani; Paul F Mansfield
Adenocarcinoma of the stomach in patients age 35 years and younger: no impact of early diagnosis on survival outcome.
Journal of surgical oncology 2002;81(3):118-24; discussion 124-5.
2002: Leonard L Gunderson; Daniel J Sargent; Joel E Tepper; Michael J O'Connell; Cristine Allmer; Steven R Smalley; James A Martenson; Daniel G Haller; Robert J Mayer; tyvin rich; Jaffer A Ajani; John S Macdonald; Richard M Goldberg
Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: a pooled analysis.
International journal of radiation oncology, biology, physics 2002;54(2):386-96.
2002: Wayne L Hofstetter; Stephen G Swisher; Arlene M Correa; Kenneth Hess; Joe B Putnam; Jaffer A Ajani; Marcelo Dolormente; Rhodette Francisco; Ritsuko Komaki; Axbal Lara; Faye Martin; David C Rice; Arcenio J Sarabia; W Roy Smythe; Ara A Vaporciyan; Garrett L Walsh; Jack A Roth
Treatment outcomes of resected esophageal cancer.
Annals of surgery 2002;236(3):376-84; discussion 384-5.
2002: Yuichi Kasakura; Jaffer A Ajani; Fumiro Mochizuki; Yukie Morishita; Masashi Fujii; Tadatoshi Takayama
Outcomes after emergency surgery for gastric perforation or severe bleeding in patients with gastric cancer.
Journal of surgical oncology 2002;80(4):181-5.
2002: Nadya Hasham-Jiwa; Yuichi Kasakura; Jaffer A Ajani
Brief review of advances in the treatment of gastric carcinoma in North America and Europe, 1995-2001.
International journal of clinical oncology 2002;7(4):219-24.
2002: Jaffer A Ajani
Preoperative therapy for patients with resectable squamous cell carcinoma of the esophagus: are we still confused?
Annals of surgical oncology 2002;9(7):605-6.
2002: Jaffer A Ajani
Docetaxel for gastric and esophageal carcinomas.
Oncology (Williston Park, N.Y.) 2002;16(6 Suppl 6):89-96.
2002: Jaffer A Ajani; Jackie Baker; Peter W T Pisters; Linus Ho; Paul F Mansfield; Barry W Feig; Chusilp Charnsangavej
Irinotecan/cisplatin in advanced, treated gastric or gastroesophageal junction carcinoma.
Oncology (Williston Park, N.Y.) 2002;16(5 Suppl 5):16-8.
2002: Yuichi Kasakura; Jaffer A Ajani; Masashi Fujii; Fumiro Mochizuki; Tadatoshi Takayama
Management of perforated gastric carcinoma: a report of 16 cases and review of world literature.
The American surgeon 2002;68(5):434-40.
2002: James C Yao; Jaffer A Ajani
Adjuvant and preoperative chemotherapy for gastric cancer.
Current oncology reports 2002;4(3):222-8.
2002: Yuichi Kasakura; Alexandria Phan; Jaffer A Ajani
Adjuvant therapy for resected gastric carcinoma.
Surgical oncology clinics of North America 2002;11(2):431-44, xii-xiii.
2002: Jaffer A Ajani; Jackie Baker; Peter W T Pisters; Linus Ho; Paul F Mansfield; Barry W Feig; Chusilp Charnsangavej
CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma: results of a phase II study.
Cancer 2002;94(3):641-6.
2002: Jaffer A Ajani
Docetaxel in combination for advanced gastric cancer.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2002;5 Suppl 1():31-4.
2002: James C Yao; Isac I Schnirer; Satish Reddy; Silvia Chiang; Azmeena Najam; Christina Yu; Geoffrey G Giacco; Kenneth Hess; Asif Rashid; Keping Xie; Patrick Lynch; Jaffer A Ajani
Effects of sex and racial/ethnic group on the pattern of gastric cancer localization.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2002;5(4):208-12.
2002: Stephen G Swisher; Paula Wynn; Joe B Putnam; Melinda B Mosheim; Arlene M Correa; Ritsuko Komaki; Jaffer A Ajani; W Roy Smythe; Ara A Vaporciyan; Jack A Roth; Garrett L Walsh
Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy.
The Journal of thoracic and cardiovascular surgery 2002;123(1):175-83.
2001: Carmen C Solorzano; Jeffrey E Lee; Peter W T Pisters; Jean-Nicolas Vauthey; Gregory D Ayers; ME Jean; Robert Gagel; Jaffer A Ajani; Robert A Wolff; Douglas B Evans
Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients.
Surgery 2001;130(6):1078-85.
2001: John S Macdonald; Steven R Smalley; Jacqueline K Benedetti; Scott A Hundahl; Norman C. Estes; Grant N Stemmermann; Daniel G Haller; Jaffer A Ajani; Leonard L Gunderson; J M Jessup; James A Martenson
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.
The New England journal of medicine 2001;345(10):725-30.
2001: Jaffer A Ajani; Ritsuko Komaki; Joe B Putnam; Garrett Walsh; Jonathan C Nesbitt; Peter W T Pisters; Patrick M Lynch; Ara A Vaporciyan; Roy Smythe; Sandeep Lahoti; Isaac Raijman; Stephen G Swisher; F D Martin; Jack A Roth
A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction.
Cancer 2001;92(2):279-86.
2001: Jaffer A Ajani; Jackie Baker; Peter W T Pisters; Linus Ho; Barry W Feig; Paul F Mansfield
Irinotecan plus cisplatin in advanced gastric or gastroesophageal junction carcinoma.
Oncology (Williston Park, N.Y.) 2001;15(3 Suppl 5):52-4.
2001: Isac I Schnirer; Ritsuko Komaki; James C Yao; Stephen G Swisher; Joe B Putnam; Peter W T Pisters; Jack A Roth; Jaffer A Ajani
Pilot study of concurrent 5-fluorouracil/paclitaxel plus radiotherapy in patients with carcinoma of the esophagus and gastroesophageal junction.
American journal of clinical oncology 2001;24(1):91-5.
2001: Barbara Pro; R Lozano; Jaffer A Ajani
Therapeutic response to octreotide in patients with refractory CPT-11 induced diarrhea.
Investigational new drugs 2001;19(4):341-3.
2000: Stephen G Swisher; Peter W T Pisters; Ritsuko Komaki; Sandeep Lahoti; Jaffer A Ajani
Gastroesophageal junction adenocarcinoma.
Current treatment options in oncology 2000;1(5):387-98.
2000: Ritsuko Komaki; Nora Janjan; Jaffer A Ajani; Patrick M Lynch; JS Fairweather; Isaac Raijman; G R Blumenshein; Linus Ho; Peter W T Pisters; Barry W Feig; G L Walsh; Richard Pazdur
Phase I study of irinotecan and concurrent radiation therapy for upper GI tumors.
Oncology (Williston Park, N.Y.) 2000;14(12 Suppl 14):34-7.
2000: Jaffer A Ajani; JS Fairweather; Peter W T Pisters; Chusilp Charnsangavej
Irinotecan and cisplatin in advanced gastric or gastroesophageal junction carcinoma.
Oncology (Williston Park, N.Y.) 2000;14(12 Suppl 14):19-21.
2000: Jaffer A Ajani
The evolving role of irinotecan: a broad-spectrum chemotherapeutic agent. Introduction.
Oncology (Williston Park, N.Y.) 2000;14(12 Suppl 14):17-8.
2000: J C Yao; Jaffer A Ajani
Gastric cancer.
Current opinion in gastroenterology 2000;16(6):516-21.
2000: Stephen G Swisher; L Deford; Kelly W Merriman; Garrett L Walsh; Roy Smythe; A Vaporicyan; Jaffer A Ajani; T Brown; Ritsuko Komaki; Jack A Roth; Joe B Putnam
Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer.
The Journal of thoracic and cardiovascular surgery 2000;119(6):1126-32.
2000: Jaffer A Ajani; James C Yao
Preoperative therapy for local-regional gastric cancer: rationale and review of trials.
Gan to kagaku ryoho. Cancer & chemotherapy 2000;27 Suppl 2():392-4.
2000: Jaffer A Ajani; David P Kelsen; D Haller; K Hargraves; D Healey
A multi-institutional phase II study of BMS-182248-01 (BR96-doxorubicin conjugate) administered every 21 days in patients with advanced gastric adenocarcinoma.
Cancer journal (Sudbury, Mass.) 2000;6(2):78-81.
2000: C D Medgyesy; Robert A Wolff; Joe B Putnam; Jaffer A Ajani
Small cell carcinoma of the esophagus: the University of Texas M. D. Anderson Cancer Center experience and literature review.
Cancer 2000;88(2):262-7.
1999: Julie E York; J Stringer; Jaffer A Ajani; David M Wildrick; Ziya L Gokaslan
Gastric cancer and metastasis to the brain.
Annals of surgical oncology 1999;6(8):771-6.
1999: J C Yao; K Shimada; Jaffer A Ajani
Adjuvant therapy for gastric carcinoma: closing out the century.
Oncology (Williston Park, N.Y.) 1999;13(11):1485-94; discussion 1497-502 passim.
1999: K Shimada; Jaffer A Ajani
Adjuvant therapy for gastric carcinoma patients in the past 15 years: a review of western and oriental trials.
Cancer 1999;86(9):1657-68.
1999: Jaffer A Ajani; Paul F Mansfield; Patrick M Lynch; Peter W T Pisters; Barry W Feig; P Dumas; Douglas B Evans; Isaac Raijman; K Hargraves; Steven A Curley; D M Ota
Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(8):2403-11.
1999: S Partyka; P Dumas; Jaffer A Ajani
Combination chemotherapy with granulocyte-macrophage-colony stimulating factor in patients with locoregional and metastatic gastric adenocarcinoma.
Cancer 1999;85(11):2336-9.
1999: Jaffer A Ajani; P F Mansfield; P Dumas
Oral etoposide for patients with metastatic gastric adenocarcinoma.
The cancer journal from Scientific American 1999;5(2):112-4.
1999: Andrew M Lowy; Paul F Mansfield; Steven D Leach; R Pazdur; P Dumas; Jaffer A Ajani
Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer.
Annals of surgery 1999;229(3):303-8.
1999: Jaffer A Ajani; H Takiuchi
Recent developments in oral chemotherapy options for gastric carcinoma.
Drugs 1999;58 Suppl 3():85-90.
1999: Y H Kim; Jaffer A Ajani; C H Carrasco; P Dumas; W Richli; D Lawrence; VP Chuang; Sidney Wallace
Selective hepatic arterial chemoembolization for liver metastases in patients with carcinoid tumor or islet cell carcinoma.
Cancer investigation 1999;17(7):474-8.
1998: David P Kelsen; Robert J Ginsberg; Thomas F Pajak; D G Sheahan; Leonard L Gunderson; J Mortimer; Norman C. Estes; Daniel G Haller; Jaffer A Ajani; Walter Kocha; Bruce D Minsky; J A Roth
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer.
The New England journal of medicine 1998;339(27):1979-84.
1998: Jaffer A Ajani
Chemotherapy for gastric carcinoma: new and old options.
Oncology (Williston Park, N.Y.) 1998;12(10 Suppl 7):44-7.
1998: Jaffer A Ajani
Current status of therapy for advanced gastric carcinoma.
Oncology (Williston Park, N.Y.) 1998;12(8 Suppl 6):99-102.
1998: Isaac Raijman; Iqbal Siddique; Jaffer A Ajani; P Lynch
Palliation of malignant dysphagia and fistulae with coated expandable metal stents: experience with 101 patients.
Gastrointestinal endoscopy 1998;48(2):172-9.
1998: H Takiuchi; Jaffer A Ajani
Uracil-tegafur in gastric carcinoma: a comprehensive review.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2877-85.
1998: Jaffer A Ajani; JS Fairweather; P Dumas; Yehuda Z Patt; Richard Pazdur; P F Mansfield
Phase II study of Taxol in patients with advanced gastric carcinoma.
The cancer journal from Scientific American 1998;4(4):269-74.
1998: David H Ilson; Jaffer A Ajani; Kapil N Bhalla; Arlene A Forastiere; Y Huang; P Patel; L Martin; J Donegan; R Pazdur; Carolyn E Reed; David P Kelsen
Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(5):1826-34.
1998: E Rivera; Jaffer A Ajani
Doxorubicin, streptozocin, and 5-fluorouracil chemotherapy for patients with metastatic islet-cell carcinoma.
American journal of clinical oncology 1998;21(1):36-8.
1998: E Diamandidou; Jaffer A Ajani; D J Yang; VP Chuang; C A Brown; Humberto Carrasco; DD Lawrence; Sidney Wallace
Two-phase study of hepatic artery vascular occlusion with microencapsulated cisplatin in patients with liver metastases from neuroendocrine tumors.
AJR. American journal of roentgenology 1998;170(2):339-44.
1998: E Thomas; P Dumas; Jaffer A Ajani
Oral etoposide for patients with advanced adenocarcinoma of the pancreas.
Investigational new drugs 1998;16(4):333-5.
1998: Jaffer A Ajani; Richard Pazdur; P Dumas; JS Fairweather
Phase II study of prolonged infusion of Taxol in patients with metastatic colorectal carcinoma.
Investigational new drugs 1998;16(2):175-7.
1997: Jaffer A Ajani
Treatment of patients with upper gastrointestinal carcinomas.
Seminars in oncology 1997;24(6 Suppl 19):S19-72-S19-76.
1997: Richard Pazdur; C Meyers; EA Diaz-Canton; James L Abbruzzese; Yehuda Z Patt; W Grove; Jaffer A Ajani
Phase II trial of intravenous CI-980 (NSC 370147) in patients with metastatic colorectal carcinoma. Model for prospective evaluation of neurotoxicity.
American journal of clinical oncology 1997;20(6):573-6.
1996: Jaffer A Ajani; David H Ilson; David P Kelsen
Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.
Seminars in oncology 1996;23(5 Suppl 12):55-8.
1996: Andrew M Lowy; Paul F Mansfield; Steven D Leach; Jaffer A Ajani
Laparoscopic staging for gastric cancer.
Surgery 1996;119(6):611-4.
1996: Sidney Wallace; Jaffer A Ajani; Chusilp Charnsangavej; Ronelle A DuBrow; David J Yang; V P Chuang; C H Carrasco; G D Dodd
Carcinoid tumors: imaging procedures and interventional radiology.
World journal of surgery 1996;20(2):147-56.
1996: H M Jeon; Patrick M Lynch; L Howard; Jaffer A Ajani; Bernard Levin; Marsha L Frazier
Mutation of the hMSH2 gene in two families with hereditary nonpolyposis colorectal cancer.
Human mutation 1996;7(4):327-33.
1995: Richard Pazdur; B Bready; Jaffer A Ajani; James L Abbruzzese; A Markowitz; S Sugarman; D Jones; Bernard Levin
Phase II trial of isotretinoin and recombinant interferon alfa-2a in metastatic colorectal carcinoma.
American journal of clinical oncology 1995;18(5):436-8.
1995: Jaffer A Ajani; David H Ilson; David P Kelsen
The activity of paclitaxel in gastrointestinal tumors.
Seminars in oncology 1995;22(5 Suppl 12):46-50; discussion 51-3.
1995: tyvin rich; John M Skibber; Jaffer A Ajani; D J Buchholz; Karen R Cleary; Ronelle A DuBrow; Bernard Levin; Patrick M Lynch; S H Meterissian; L D Roubein
Preoperative infusional chemoradiation therapy for stage T3 rectal cancer.
International journal of radiation oncology, biology, physics 1995;32(4):1025-9.
1995: Jaffer A Ajani; David H Ilson; K Daugherty; David P Kelsen
Paclitaxel in the treatment of carcinoma of the esophagus.
Seminars in oncology 1995;22(3 Suppl 6):35-40.
1995: G D Weinstein; tyvin rich; C R Shumate; John M Skibber; Karen R Cleary; Jaffer A Ajani; D M Ota
Preoperative infusional chemoradiation and surgery with or without an electron beam intraoperative boost for advanced primary rectal cancer.
International journal of radiation oncology, biology, physics 1995;32(1):197-204.
1995: Jaffer A Ajani; Paul F Mansfield; D M Ota
Potentially resectable gastric carcinoma: current approaches to staging and preoperative therapy.
World journal of surgery 1995;19(2):216-20.
1995: Y H Kim; Jaffer A Ajani; D M Ota; P Lynch; Jack A Roth
Value of serial carcinoembryonic antigen levels in patients with resectable adenocarcinoma of the esophagus and stomach.
Cancer 1995;75(2):451-6.
1995: Steven D Leach; Andrew M Lowy; Paul F Mansfield; Jaffer A Ajani
Adjuvant therapy for resectable gastric adenocarcinoma: preoperative and postoperative chemotherapy trials.
The Journal of infusional chemotherapy 1995;5(3):104-11.
1995: Jaffer A Ajani
Therapy of carcinoma of the oesophagus: either attempt it not or succeed.
European journal of cancer (Oxford, England : 1990) 1995;31A(5):790-3.
1995: Jaffer A Ajani; Jack A Roth; Joe B Putnam; G Walsh; Patrick M Lynch; L D Roubein; M B Ryan; G Natrajan; P Gould
Feasibility of five courses of pre-operative chemotherapy in patients with resectable adenocarcinoma of the oesophagus or gastrooesophageal junction.
European journal of cancer (Oxford, England : 1990) 1995;31A(5):665-70.
1994: Richard Pazdur; Yvonne Lassere; V Rhodes; Jaffer A Ajani; S M Sugarman; Yehuda Z Patt; D V Jones; A B Markowitz; James L Abbruzzese; B Bready
Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(11):2296-300.
1994: Jaffer A Ajani; C H Carrasco; Sidney Wallace
Neuroendocrine tumors metastatic to the liver. Vascular occlusion therapy.
Annals of the New York Academy of Sciences 1994;733():479-87.
1994: Philip A Philip; Jaffer A Ajani
Has combined modality therapy improved the outlook in carcinoma of the esophagus?
Oncology (Williston Park, N.Y.) 1994;8(9):37-42; discussion 44-5, 50-2, 61.
1994: Jaffer A Ajani
Contributions of chemotherapy in the treatment of carcinoma of the esophagus: results and commentary.
Seminars in oncology 1994;21(4):474-82.
1994: Jaffer A Ajani; David H Ilson; K Daugherty; Richard Pazdur; Patrick M Lynch; David P Kelsen
Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus.
Journal of the National Cancer Institute 1994;86(14):1086-91.
1994: Richard Pazdur; Yvonne Lassere; L T Soh; Jaffer A Ajani; B Bready; E Soo; S Sugarman; Yehuda Z Patt; James L Abbruzzese; Bernard Levin
Phase II trial of docetaxel (Taxotere) in metastatic colorectal carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(5):468-70.
1994: D F Moore; Richard Pazdur; James L Abbruzzese; Jaffer A Ajani; D W Dubovsky; James L Wade Iii; R J Belt; C Mangold; B Bready; RJ Winn
Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(3):286-7.
1994: R Vassilopoulou-Sellin; Jaffer A Ajani
Islet cell tumors of the pancreas.
Endocrinology and metabolism clinics of North America 1994;23(1):53-65.
1994: S Meterissian; John M Skibber; T Rich; L Roubein; Jaffer A Ajani; Karen Cleary; D M Ota
Patterns of residual disease after preoperative chemoradiation in ultrasound T3 rectal carcinoma.
Annals of surgical oncology 1994;1(2):111-6.
1994: Jaffer A Ajani; L G Dodd; K Daugherty; Dawn I Warkentin; David H Ilson
Taxol-induced soft-tissue injury secondary to extravasation: characterization by histopathology and clinical course.
Journal of the National Cancer Institute 1994;86(1):51-3.
1994: T A Rich; Jaffer A Ajani
High dose external beam radiation therapy with or without concomitant chemotherapy for esophageal carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 3():9-15.
1994: T A Rich; Douglas B Evans; Steven A Curley; Jaffer A Ajani
Adjuvant radiotherapy and chemotherapy for biliary and pancreatic cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 3():75-80.
1994: Jaffer A Ajani; Rodger Winn; L Baez; T Pollock; T Maher; B Hallinan-Fueger; J Newman
Phase II study of merbarone (NSC 336628) in patients with advanced gastric carcinoma.
Cancer investigation 1994;12(5):488-90.
1993: Douglas B Evans; John M Skibber; Jeffrey E Lee; Karen R Cleary; Jaffer A Ajani; Robert Gagel; Rena V Sellin; CJ Fenoglio; R C Merrell; R C Hickey
Nonfunctioning islet cell carcinoma of the pancreas.
Surgery 1993;114(6):1175-81; discussion 1181-2.
1993: Jaffer A Ajani; R J Mayer; D M Ota; Glenn Steele; D Evans; M Roh; D J Sugarbaker; P Dumas; C Gray; D A Vena
Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma.
Journal of the National Cancer Institute 1993;85(22):1839-44.
1993: D V Jones; Yehuda Z Patt; Jaffer A Ajani; James L Abbruzzese; C H Carrasco; Chusilp Charnsangavej; Bernard Levin; Sidney Wallace
A phase I-II trial of mitoxantrone by hepatic arterial infusion in patients with hepatocellular carcinoma or colorectal carcinoma metastatic to the liver.
Cancer 1993;72(9):2560-3.
1993: L D Roubein; Ronelle A DuBrow; C David; P Lynch; B Fornage; Jaffer A Ajani; J Roth; Bernard Levin
Endoscopic ultrasonography in the quantitative assessment of response to chemotherapy in patients with adenocarcinoma of the esophagus and esophagogastric junction.
Endoscopy 1993;25(9):587-91.
1993: C R Shumate; tyvin rich; John M Skibber; Jaffer A Ajani; D M Ota
Preoperative chemotherapy and radiation therapy for locally advanced primary and recurrent rectal carcinoma. A report of surgical morbidity.
Cancer 1993;71(11):3690-6.
1993: tyvin rich; Jaffer A Ajani; William H Morrison; D Ota; B Levin
Chemoradiation therapy for anal cancer: radiation plus continuous infusion of 5-fluorouracil with or without cisplatin.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1993;27(3):209-15.
1993: Richard Pazdur; Jaffer A Ajani; Yehuda Z Patt; J Gomez; B Bready; Bernard Levin
Phase II evaluation of recombinant alpha-2a-interferon and continuous infusion fluorouracil in previously untreated metastatic colorectal adenocarcinoma.
Cancer 1993;71(4):1214-8.
1993: Jaffer A Ajani; James L Abbruzzese; A B Markowitz; Yehuda Z Patt; K Daugherty
Phase II study of etoposide and alpha-interferon in patients with advanced measurable colorectal carcinoma.
Investigational new drugs 1993;11(1):67-9.
1993: Jaffer A Ajani; Jack A Roth; M B Ryan; Joe B Putnam; Richard Pazdur; Bernard Levin; Jordan U Gutterman; M McMurtrey
Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(1):22-8.
1993: D V Jones; Jaffer A Ajani; RJ Winn; K R Daugherty; Bernard Levin; I H Krakoff
A phase II study of merbarone in patients with adenocarcinoma of the pancreas.
Cancer investigation 1993;11(6):667-9.
1992: Jaffer A Ajani; P Dumas
Evaluation of oral etoposide in patients with metastatic gastric carcinoma: a preliminary report.
Seminars in oncology 1992;19(6 Suppl 14):45-7.
1992: K P Hubbard; Richard Pazdur; Jaffer A Ajani; E Braud; A Blaustein; M King; M Llenado-Lee; Rodger Winn; Bernard Levin; James L Abbruzzese
Phase II evaluation of iproplatin in patients with advanced gastric and pancreatic cancer.
American journal of clinical oncology 1992;15(6):524-7.
1992: D V Jones; N A Samaan; Rena V Sellin; Jaffer A Ajani
Metastatic glucagonoma: clinical response to a combination of 5-fluorouracil and alpha-interferon.
The American journal of medicine 1992;93(3):348-9.
1992: D V Jones; Jaffer A Ajani; R Blackburn; K Daugherty; Bernard Levin; Yehuda Z Patt; James L Abbruzzese
Phase II study of didemnin B in advanced colorectal cancer.
Investigational new drugs 1992;10(3):211-3.
1992: V B Grossie; K Nishioka; Jaffer A Ajani; D M Ota
Substituting ornithine for arginine in total parenteral nutrition eliminates enhanced tumor growth.
Journal of surgical oncology 1992;50(3):161-7.
1992: K P Hubbard; K Daugherty; Jaffer A Ajani; Richard Pazdur; Bernard Levin; James L Abbruzzese
Phase II trial of fazarabine in advanced colorectal carcinoma.
Investigational new drugs 1992;10(1):39-42.
1992: Richard Pazdur; Jaffer A Ajani; Rodger Winn; James Bearden; R J Belt; S Pilat; R Hallinan; Bernard Levin
A phase II trial of 5-fluorouracil and recombinant alpha-2a-interferon in previously untreated metastatic gastric carcinoma.
Cancer 1992;69(4):878-82.
1992: Jaffer A Ajani; B Ryan; T A Rich; M McMurtrey; Jack A Roth; L DeCaro; B Levin; C Mountain
Prolonged chemotherapy for localised squamous carcinoma of the oesophagus.
European journal of cancer (Oxford, England : 1990) 1992;28A(4-5):880-4.
1991: Jaffer A Ajani; Richard Pazdur; RJ Winn; James L Abbruzzese; Bernard Levin; R Belt; J Young; Yehuda Z Patt; I H Krakoff
Phase II study of intravenous 6-thioguanine in patients with advanced carcinoma of the pancreas.
Investigational new drugs 1991;9(4):369-71.
1991: K Linke; Richard Pazdur; James L Abbruzzese; Jaffer A Ajani; Rodger Winn; J E Bradof; K Daugherty; Bernard Levin
Phase II study of amonafide in advanced pancreatic adenocarcinoma.
Investigational new drugs 1991;9(4):353-6.
1991: V B Grossie; D M Ota; Jaffer A Ajani; K Nishioka
Amelioration of thrombocytopenia with concomitant ornithine in sarcoma-bearing rats receiving high dose difluoromethylornithine.
Investigational new drugs 1991;9(4):321-6.
1991: Jaffer A Ajani; D M Ota; J M Jessup; Frederick C Ames; C McBride; A Boddie; Bernard Levin; D E Jackson; M Roh; D Hohn
Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy.
Cancer 1991;68(7):1501-6.
1991: Jaffer A Ajani; Richard Pazdur; RJ Winn; James L Abbruzzese; Bernard Levin; C Wiseman; M A Lenado-Lee; Yehuda Z Patt; I H Krakoff
Phase II study of intravenous 6-thioguanine in patients with advanced gastric carcinoma.
Investigational new drugs 1991;9(3):257-9.
1991: K Nishioka; V B Grossie; T H Chang; Jaffer A Ajani; D M Ota
Colorectal ornithine decarboxylase activity in human mucosa and tumors: elevation of enzymatic activity in distal mucosa.
Journal of surgical oncology 1991;47(2):117-20.
1991: Kapil Dhingra; Moshe Talpaz; H M Dhingra; Jaffer A Ajani; J M Rothberg; Jordan U Gutterman
A phase I trial of recombinant alpha-2a interferon (Roferon-A) with weekly cisplatinum.
Investigational new drugs 1991;9(1):37-9.
1991: N A Ellerbroek; Frank V Fossella; tyvin rich; Jaffer A Ajani; Ritsuko Komaki; Jack A Roth; P Y Holoye
Low-dose continuous infusion cisplatin combined with external beam irradiation for advanced colorectal adenocarcinoma and unresectable non-small cell lung carcinoma.
International journal of radiation oncology, biology, physics 1991;20(2):351-5.
1991: Jaffer A Ajani; D M Ota; D E Jackson
Current strategies in the management of locoregional and metastatic gastric carcinoma.
Cancer 1991;67(1 Suppl):260-5.
1990: Richard Pazdur; Jaffer A Ajani; Yehuda Z Patt; Rodger Winn; D Jackson; B Shepard; R DuBrow; L Campos; M Quaraishi; J Faintuch
Phase II study of fluorouracil and recombinant interferon alfa-2a in previously untreated advanced colorectal carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(12):2027-31.
1990: James L Abbruzzese; Bernard Levin; Jaffer A Ajani; J S Faintuch; R Pazdur; S Saks; C Edwards; Jordan U Gutterman
A phase II trial of recombinant human interferon-gamma and recombinant tumor necrosis factor in patients with advanced gastrointestinal malignancies: results of a trial terminated by excessive toxicity.
Journal of biological response modifiers 1990;9(5):522-7.
1990: Jaffer A Ajani; Jack A Roth; B Ryan; M McMurtrey; tyvin rich; D E Jackson; James L Abbruzzese; Bernard Levin; L DeCaro; C Mountain
Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(7):1231-8.
1990: Yehuda Z Patt; L M Lamki; J Shanken; J M Jessup; Chusilp Charnsangavej; Jaffer A Ajani; Bernard Levin; B Merchant; C Halverson; James L Murray
Imaging with indium111-labeled anticarcinoembryonic antigen monoclonal antibody ZCE-025 of recurrent colorectal or carcinoembryonic antigen-producing cancer in patients with rising serum carcinoembryonic antigen levels and occult metastases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(7):1246-54.
1990: S Venkatesh; Nelson G Ordonez; Jaffer A Ajani; Pamela N Schultz; R C Hickey; Dennis A Johnston; N A Samaan
Islet cell carcinoma of the pancreas. A study of 98 patients.
Cancer 1990;65(2):354-7.
1990: Jaffer A Ajani; S R Welch; Martin N Raber; W S Fields; I H Krakoff
Comprehensive criteria for assessing therapy-induced toxicity.
Cancer investigation 1990;8(2):147-59.
1990: Jaffer A Ajani; James L Abbruzzese; J S Faintuch; Y Z Patt; B M Boman; D E Jackson; Bernard Levin; I H Krakoff
A phase II study of trimetrexate therapy for metastatic colorectal carcinoma.
Cancer investigation 1990;8(6):619-21.
1990: Jaffer A Ajani; D M Ota; V B Grossie; James L Abbruzzese; J S Faintuch; Y Z Patt; D E Jackson; Bernard Levin; K Nishioka
Evaluation of continuous-infusion alpha-difluoromethylornithine therapy for colorectal carcinoma.
Cancer chemotherapy and pharmacology 1990;26(3):223-6.
1990: C Nicaise; Jaffer A Ajani; P Goudeau; M Rozencweig; Bernard Levin; I Krakoff
Phase II study of tallysomycin S10b in patients with advanced colorectal cancer.
Cancer chemotherapy and pharmacology 1990;26(3):221-2.
1989: L L Hughes; tyvin rich; L Delclos; Jaffer A Ajani; R G Martin
Radiotherapy for anal cancer: experience from 1979-1987.
International journal of radiation oncology, biology, physics 1989;17(6):1153-60.
1989: Jaffer A Ajani; B Levin; Sidney Wallace
Systemic and regional therapy of advanced islet cell tumors.
Gastroenterology clinics of North America 1989;18(4):923-30.
1989: V B Grossie; K Nishioka; T H Chang; D Patenia; M M Benitez; Jaffer A Ajani; D M Ota
Differential effects of parenteral nutrition on tumor growth and erythrocyte polyamine levels in the rat.
JPEN. Journal of parenteral and enteral nutrition 1989;13(6):590-5.
1989: Jaffer A Ajani; D M Ota; V B Grossie; Bernard Levin; K Nishioka
Alterations in polyamine metabolism during continuous intravenous infusion of alpha-difluoromethylornithine showing correlation of thrombocytopenia with alpha-difluoromethylornithine plasma levels.
Cancer research 1989;49(20):5761-5.
1989: Jaffer A Ajani; M D Kanojia; A Y Bedikian
High-dose methotrexate and 5-fluorouracil in patients with advanced colorectal carcinoma. A randomized study of two pretreatment intervals.
American journal of clinical oncology 1989;12(4):335-8.
1989: Jaffer A Ajani; C H Carrasco; D E Jackson; Sidney Wallace
Combination of cisplatin plus fluoropyrimidine chemotherapy effective against liver metastases from carcinoma of the anal canal.
The American journal of medicine 1989;87(2):221-4.
1989: V B Grossie; D M Ota; Jaffer A Ajani; T H Chang; D Patenia; K Nishioka
Reduction of difluoromethylornithine-induced thrombocytopenia in rats with ornithine while maintaining antitumor activity.
Cancer research 1989;49(15):4159-62.
1989: James L Abbruzzese; Bernard Levin; Jaffer A Ajani; J S Faintuch; S Saks; Y Z Patt; C Edwards; K Ende; Jordan U Gutterman
Phase I trial of recombinant human gamma-interferon and recombinant human tumor necrosis factor in patients with advanced gastrointestinal cancer.
Cancer research 1989;49(14):4057-61.
1989: Jaffer A Ajani; A A Rios; K Ende; James L Abbruzzese; C Edwards; J S Faintuch; S Saks; Jordan U Gutterman; Bernard Levin
Phase I and II studies of the combination of recombinant human interferon-gamma and 5-fluorouracil in patients with advanced colorectal carcinoma.
Journal of biological response modifiers 1989;8(2):140-6.
1989: Elias Tueni; Robert A Newman; F L Baker; Jaffer A Ajani; Dominic Fan; G Spitzer
In vitro activity of bleomycin, tallysomycin S10b, and liblomycin against fresh human tumor cells.
Cancer research 1989;49(5):1099-102.
1989: Jaffer A Ajani; P Goudeau; Bernard Levin; J S Faintuch; James L Abbruzzese; B M Boman; M D Kanojia
Phase II study of adriamycin with sequential methotrexate and 5-fluorouracil (AMF) in gastric carcinoma.
Cancer chemotherapy and pharmacology 1989;24(1):41-4.
1988: K Nishioka; V B Grossie; Jaffer A Ajani; D Patenia; T H Chang; D M Ota
Polyamine-directed preferential nutritional repletion of normal tissues in tumor-bearing hosts.
International journal of cancer. Journal international du cancer 1988;42(5):744-7.
1988: Jaffer A Ajani; James L Abbruzzese; P Goudeau; J S Faintuch; A C Yeomans; B M Boman; C Nicaise; Bernard Levin
Ifosfamide and mesna: marginally active in patients with advanced carcinoma of the pancreas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(11):1703-7.
1988: V B Grossie; D M Ota; Jaffer A Ajani; T H Chang; D Patenia; K Nishioka
Influence of total parenteral nutrition on tumor growth and polyamine biosynthesis of fibrosarcoma-bearing rats after induced cachexia.
JPEN. Journal of parenteral and enteral nutrition 1988;12(5):441-4.
1988: D Fan; F L Baker; A R Khokhar; Jaffer A Ajani; B Tomasovic; R A Newman; W A Brock; E Tueni; G Spitzer
Antitumor activity against human tumor samples of cis-diamminedichloroplatinum(II) and analogues at equivalent in vitro myelotoxic concentrations.
Cancer research 1988;48(11):3135-9.
1988: Jaffer A Ajani; F L Baker; G Spitzer
In vitro activity of amonafide against primary human tumors compared with the activity of standard agents.
Investigational new drugs 1988;6(2):79-85.
1988: Jaffer A Ajani; James L Abbruzzese; J S Faintuch; R Blackburn; Bernard Levin; B M Boman
Phase II study of fludarabine phosphate in patients with advanced colorectal carcinoma.
Investigational new drugs 1988;6(1):47-50.
1988: F L Baker; Jaffer A Ajani; G Spitzer; B J Tomasovic; M Williams; M Finders; W A Brock
High colony-forming efficiency of primary human tumor cells cultured in the adhesive-tumor-cell culture system: improvements with medium and serum alterations.
International journal of cell cloning 1988;6(2):95-105.
1988: Jaffer A Ajani; C H Carrasco; C Charnsangavej; N A Samaan; B Levin; Sidney Wallace
Islet cell tumors metastatic to the liver: effective palliation by sequential hepatic artery embolization.
Annals of internal medicine 1988;108(3):340-4.
1987: Jaffer A Ajani; F L Baker; G Spitzer; A Kelly; W Brock; B Tomasovic; S Eva Singletary; M McMurtrey; C Plager
Comparison between clinical response and in vitro drug sensitivity of primary human tumors in the adhesive tumor cell culture system.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(12):1912-21.
1987: D Fan; Jaffer A Ajani; F L Baker; B Tomasovic; W A Brock; G Spitzer
Comparison of antitumor activity of standard and investigational drugs at equivalent granulocyte-macrophage colony-forming cell inhibitory concentrations in the adhesive tumor cell culture system: an in vitro method of screening new drugs.
European journal of cancer & clinical oncology 1987;23(10):1469-76.
1987: Jaffer A Ajani; G N Hortobagyi; D Frye; Bernard Levin; B M Boman; J S Faintuch
A randomized study of two schedules of copovithane in patients with advanced colorectal carcinoma.
American journal of clinical oncology 1987;10(2):139-40.
1987: V B Grossie; D M Ota; Jaffer A Ajani; K Nishioka
Effect of intravenous alpha-difluoromethylornithine on the polyamine levels of normal tissue and a transplantable fibrosarcoma.
Cancer research 1987;47(7):1836-40.
1987: S E Singletary; F L Baker; G Spitzer; S L Tucker; B Tomasovic; W A Brock; Jaffer A Ajani; A M Kelly
Biological effect of epidermal growth factor on the in vitro growth of human tumors.
Cancer research 1987;47(2):403-6.
1986: Yehuda Z Patt; A W Boddie; Chusilp Charnsangavej; Jaffer A Ajani; S Wallace; M Soski; L Claghorn; G M Mavligit
Hepatic arterial infusion with floxuridine and cisplatin: overriding importance of antitumor effect versus degree of tumor burden as determinants of survival among patients with colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(9):1356-64.
1986: D M Ota; V B Grossie; Jaffer A Ajani; L C Stephens; K Nishioka
Red blood cell polyamine levels and host toxicity during continuous alpha-difluoromethylornithine infusion.
International journal of cancer. Journal international du cancer 1986;38(2):245-9.
1986: C C Adolphson; Jaffer A Ajani; J R Stroehlein; Bart Barlogie; Gerald P Bodey; J Korinek; A Y Bedikian
Phase II trial of acivicin in patients with advanced colorectal carcinoma.
American journal of clinical oncology 1986;9(3):189-91.
1986: F L Baker; G Spitzer; Jaffer A Ajani; W A Brock; J Lukeman; Sen Pathak; B Tomasovic; D Thielvoldt; M Williams; C Vines
Drug and radiation sensitivity measurements of successful primary monolayer culturing of human tumor cells using cell-adhesive matrix and supplemented medium.
Cancer research 1986;46(3):1263-74.
1986: G E Umbach; G Spitzer; Jaffer A Ajani; V Hug; H Thames; F B Rudolph; B Drewinko
Role of culture conditions and exposure duration in determining sensitivity of human bone marrow progenitor cells to methotrexate.
Journal of cancer research and clinical oncology 1986;111(3):273-6.
1986: Jaffer A Ajani; J S Faintuch; R K McClure; Bernard Levin; B M Boman; I H Krakoff
Phase II study of spirogermanium in patients with advanced colorectal carcinoma.
Investigational new drugs 1986;4(4):383-5.
1986: Jaffer A Ajani; B Tomasovic; G Spitzer; J J Kavanagh; D Thielvoldt; F L Baker; D Gershenson
Activity of 2-fluoro-Ara AMP against gynecologic tumors in the soft agar assay.
Investigational new drugs 1986;4(2):141-8.
1985: W B Harris; V B Grossie; D M Ota; K Nishioka; Jaffer A Ajani; T Chang; D Patenia
Effect of difluoromethylornithine on host and tumor polyamine metabolism during total parenteral nutrition.
The Journal of surgical research 1985;38(6):592-8.
1985: S Eva Singletary; G E Umbach; G Spitzer; B Drewinko; B Tomasovic; Jaffer A Ajani; V Hug; G Blumenschein
The human tumor stem cell assay revisited.
International journal of cell cloning 1985;3(2):116-28.
1985: Jaffer A Ajani; M D Kanojia; A Y Bedikian; J K Korinek; S H Stein; E G Espinoza; Gerald P Bodey
Sequential methotrexate and 5-fluorouracil in the primary treatment of metastatic colorectal carcinoma.
American journal of clinical oncology 1985;8(1):69-71.
1985: G E Umbach; V Hug; G Spitzer; B Tomasovic; H Thames; Jaffer A Ajani; B Drewinko
Survival of human bone marrow cells after in vitro treatment with 12 anticancer drugs and implications for tumor drug sensitivity assays.
Journal of cancer research and clinical oncology 1985;109(2):130-4.
1985: Jaffer A Ajani; A A Blaauw; G Spitzer; F L Baker; B Tomasovic; G Umbach; D Thielvoldt; A R Zander; K A Dicke
Differential cytotoxic activity of chemotherapy agents on colony-forming cells from human tumors and normal bone marrow in vitro.
Experimental hematology 1985;13 Suppl 16():95-100.
1984: G Spitzer; F Baker; G Umbach; V Hug; B Tomasovic; Jaffer A Ajani; M Haynes; S K Sahu
Growth factor enhancement of the in vitro stem cell assay.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1984;94():253-66.